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An individual’s naïve level of response (LR) to ethanol is predictive of their lifetime 
likelihood to abuse alcohol. LR is heavily genetically influenced, suggesting that the 
genes responsible for LR may also be central to the development of abuse disorders. 
Our laboratory uses the model organism C. elegans to investigate the genetic 
influences on responses to acute ethanol exposure. We recently found that changes in 
TAG levels can alter LR. From this result we investigated the role of long-chain 
polyunsaturated fatty acids (LC-PUFAs) as well enzymes involved in lipid modifications 
of proteins. We found that LC-PUFAs are necessary for acute functional tolerance and 
that supplementation of eicosapentaenoic acid is able to rescue AFT. We also identified 
mutations in several palmitoyltransferases, a thioesterase, and elongases that alter 
AFT. These novel results highlight the importance of fatty acids in the response to 
ethanol and suggest exciting new potential therapeutic targets.  
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5 Introduction and Background 
5.1 Alcohol use and abuse 
Alcohol abuse disorders (AUD) affect approximately eighteen million Americans 
and are estimated to cost the United States approximately 2% of its GDP each year [1, 
2]. Data collected by the World Health Organization indicates that in the US 5.48% of 
males and 1.92% of females 15 years or older suffer from an AUD. Considering that this 
amounts to roughly 1 in 20 males and 1 in 50 females that are directly affected by 
alcohol it may not be surprising that 43% of US adults, 76 million people when this study 
was conducted and 135 million today, have been exposed to alcoholism in their family 
[3]. A recent study found that the involvement of alcohol in motor vehicle deaths is 
profoundly underreported [4]. National mortality statistics often use the cause of death 
on death certificates as a way of tracking the number of alcohol related traffic deaths. 
The cause of death listed in the Multiple Cause of Death (MCoD) database, run by the 
National Center for Health Statistics, is often listed prior to toxicological analysis of 
blood work or only considers the traffic accident as the cause of death. The Fatal 
Analysis Reporting System (FARS), maintained by the National Highway Traffic Safety 
Administration, lists multiple influencing factors that lead to the motor vehicle related 
death including blood alcohol concentrations of 0.08% and higher. Analysis of the 
MCoD data found that 3.3% of the motor vehicle traffic deaths from 1999-2009 were 
alcohol related while analysis of the more complete FARS data found that in 21.1% of 
motor vehicle traffic deaths the deceased had a BAC of 0.08% or higher. The study’s 
authors further hypothesized that underreporting is likely occurring for other alcohol-
related fatalities [4]. 
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Despite the seriousness of AUD, current pharmacological interventions are 
inadequate. This is due, in part, to the complexity of alcohol’s molecular effects. The 
following introduction will summarize some of the known ethanol responsive proteins, 
the signaling pathways that are affected, as well a brief summary of the genetics 
underlying AUD.  
 
5.2 Molecular targets of ethanol 
 
Ethanol is a two carbon, polar, organic molecule with a single hydroxyl group that 
allows for hydrogen bonding. It is the simplicity of this molecule that allows it so many 
interactions in vivo. It has been hypothesized that ethanol may compete with water 
molecules or lipids in binding domains of target proteins [5]. This sheer number of 
possible interactions makes targeted pharmacological intervention difficult. This section 
will summarize some of the data that supports direct interactions between ethanol and 
proteins. A later section, Ethanol and Neurotransmission, will tie-in the effects of ethanol 
interacting with these proteins in neurotransmission.  
 
5.2.1 N-methyl-D-Aspartate (NMDA) receptors 
In 1989 David Lovinger found that NMDA function in hippocampal neurons was 
dose-dependently inhibited by biologically relevant doses of ethanol [6]. In support of a 
direct effect-interaction, single-channel recordings were consistent with ethanol acting 
as an allosteric modulator of NMDA [7]. Site directed mutagenesis identified several key 
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residues for ethanol’s inhibitory actions between transmembrane (TM) domains 3 and 4 
[8-11]. The identification of these residues strongly supported the hypothesis that 
ethanol acted directly on the channel. In further support of ethanol in interacting with 
NMDA receptors, non-competitive NDMA antagonists substituted for ethanol in drug 
discrimination in mice [12]. The inhibition of NMDA by ethanol likely results in the 
anesthetic effects of ethanol.  
 
5.2.2 Ionotropic γ-aminobutyric acid (GABAA) receptors 
A very large body of work has been dedicated to understanding GABA’s role in 
intoxication, especially at low doses. GABAA is a pentameric, ligand-gated ion channel 
that is permeable to chloride ions. GABAA channels can be composed of various 
combinations of six different α subunits, three β subunits, three γ subunits, one δ, one ε, 
one pi, one θ, and three ρ subunits. The minimal requirement for channel formation is 
the presence of at least one α and one β subunit [13]. Activation of the channel causes 
hyperpolarization of the neuron and inhibits firing. GABAA activity has been shown to be 
enhanced by ethanol. Two specific amino-acid residues in TM domains 2 and 3 are 
critical for modulation of the channel by ethanol [14]. These data suggested that a 
binding pocket exists between the α-helices [15]. Work in the TM domains of glycine 
receptors found a similar binding pocket. Mutating these residues to cysteines revealed 
that disulfide bonds could form and thus the residues were in a close enough proximity 
to accommodate ethanol [15]. Application of propyl methanethiosulfonate, which binds 
irreversibly to cysteine residues, produced irreversible changes in the receptor function 
which further supported the hypothesis that these residues were accessible to ethanol 
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and were involved in the response it elicited [16]. The numerous combination of GABAA 
subunits combined with the challenge in expressing specific combinations in vitro led to 
controversy over which subunits were sensitive to ethanol and at what ethanol 
concentrations [17, 18]. There is now a general consensus that channels containing β3 
and δ subunits are sensitive to low doses of ethanol and are hypothesized to be 
involved in the activating response to ethanol [17] which may be involved in the 
alcohol’s disinhibiting effects [19].  
 
5.2.3 Glycine receptors 
Like GABAA channels, the opening of glycine channels results in an influx of 
chloride ions and results in inhibition. Likewise, their activity is also enhanced by ethanol 
[14, 20]. Glycine receptors are also pentameric, ligand-gated ion channels that are 
composed of four different α subunits and one β subunit. Similarity in the α-helical TM 
domains of GABAA and glycine receptors suggests that ethanol binds between these 
domains [14, 15]. Glycine receptors are also pentameric ions channels with variations in 
subunit composition modulating the response to ethanol. Specifically, channels 
containing the α1 and α2 subunits have been shown to be more sensitive to the 
potentiating effects of ethanol [21]. Activation of glycine receptors by ethanol may be 
involved in dopamine release and the subsequent rewarding effects [22, 23] however 
the localization of the glycine receptors likely matters as inhibition of glycine 
transporters can reduce ethanol intake and preference in rats [24].  
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5.2.4 Nicotinic acetylcholine receptors 
Another of the pentameric, ligand-gated, ion channels that ethanol interacts with 
are the nicotinic acetylcholine receptors (nAChRs). Electrophysiological studies of 
human neuronal nAChRs expressed in Xenopus oocytes showed that short-chain 
alcohols, including ethanol, potentiate the channel activity for a variety of subunit 
combinations [25]. High doses of ethanol, greater than 100 mM, have been shown to 
potentiate neuronal nAChRs [26] while doses below this only potentiate α2β4*, α4β4*, 
α2β2*, α4β2* receptors[27]. α3β2* and α3β4* have been shown to be unaffected by ethanol 
while the homomeric α7 receptor is inhibited [27]. Activation of dopamine-stimulating 
nAChRs in the VTA have been shown to promote ethanol-seeking behavior [28]. 
 
5.2.5 Serotonin receptors (5-HT3) 
Another of the ligand-gated ion channels that are potentiated by ethanol is the 5-
HT3 receptor [29, 30]. These channels are permeable to Na+, K+, and Ca2+ ions and are 
excitatory. Ethanol potentiation of 5-HT3 has been shown in numerous in vitro 
preparations [31]. Mutation of amino acids in TM1 and TM2 domains have been shown 
to alter the potentiating effects of ethanol, suggesting that an ethanol binding site may 
exist between these domains [32, 33] much the same as in GABAA and glycine 
receptors. Ethanol increases the open probability of 5-HT3 without altering agonist 
affinity for the channels [34] which suggests that activation of 5-HT3 in the presence of 
ethanol may result in its rewarding effects.  
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5.2.6 L-type calcium channels 
Voltage-gated L-type calcium channels are inhibited by ethanol and data from 
single channel recordings is consistent with a model of a single drug molecule acting on 
a single target site [35]. Voltage-gated L-type channel opening results in the influx of 
mainly Ca2+ ions and, depending on the cell type it is expressed, leads to neuronal 
firing. The inhibition of this channel by ethanol would be predicted to decrease synaptic 
transmission.  
 
5.2.7 G protein-coupled inwardly-rectifying potassium (GIRK) channels 
GIRK channel activity is enhanced by ethanol and is dependent on a region of 43 
amino acids in the carboxy terminus [36, 37]. GIRK channels are opened in vivo by the 
βγ subunits of activated G-protein coupled receptors (GPCRs) and this causes an 
outward flow of K+ ions and hyperpolarization of the neuron [38]. This suggests that 
activation of GIRK channels by ethanol may result in hyperpolarization of neurons and a 
decrease in synaptic signaling.  
 
5.2.8 Big potassium (BK) channels 
BK channels, also known as SLO-1 channels in C. elegans and Drosophila 
melanogaster, are voltage-gated ion channels permeable to potassium and their 
activation is necessary for repolarizing neurons. Electrophysiological work in various 
membranes, including artificial membranes where lipid species and proteins can be 
selected, supported a direct interaction between the channel and ethanol. The activation 
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of the channel was also shown to be modulated by the lipid environment surrounding 
the channel [39-45]. This channel was first identified as a possible target of ethanol in C. 
elegans by a forward genetic screen for mutants that were resistant to the locomotor 
decreasing effects of ethanol [39]. The continued activation of the BK channel by 
ethanol is predicted to cause hyperpolarization of neurons and a decrease in synaptic 
firing.  
 
5.3 Ethanol and neurotransmission 
Drug substitution studies can be used to assess if a drug with a known 
mechanism of action functions in a similar way as one with an unknown mechanism. 
Briefly, a mouse or rat is trained to press a lever in a response to an injection of vehicle 
or drug. Once a the rodent can discriminate between the drug and the vehicle, a 
researcher can then give a different drug and allow the rodent to press either lever. By 
doing this the researchers can ask if the novel drug “feels” like the training drug to the 
rodent. These studies have shown that GABA-mimetic drugs completely substitute for 
ethanol. Both competitive and noncompetitive NMDA receptor antagonists are capable 
of substituting for ethanol. Some antagonists of strychnine-insensitive glycine 
modulatory sites among the NMDA receptor complex dose-dependently substitute for 
the ethanol discriminative stimulus in trained mice [46]. These studies help to support 
previous studies that found interactions between GABAA, NMDA, and glycine receptors 
and support pathways that ethanol affects.  
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Perhaps the most studied system in drug reinforcement is the dopaminergic 
(DAergic) system. The release of dopamine (DA) activates various DA receptors. D1-
like receptors, which include D1 and D5 receptors, enhance the activity of adenylyl 
cyclase (AC) through their coupling to the stimulatory Gαs containing GPCRs. D2-like 
receptors, D2 through D4, inhibit AC through inhibitory Gi/o GPCRs. D1-like receptor 
activation results in an increase in the concentration of cAMP and the activation of 
cAMP-dependent protein kinase A (PKA) signaling, which then leads to substrate 
phosphorylation [47]. This signaling cascade can lead to numerous changes in protein 
function and gene expression. 
Alcohol enhances DAergic activity in the nucleus accumbens (NAC) shell region 
which has been shown to be involved in both the acute rewarding [48] and chronic 
neuroadaptive changes elicited by ethanol [49]. Dopamine, GABA, and 5-HT are the 
major neurotransmitters in the NAC shell. Low systemic doses of ethanol dose-
dependently increase the firing rate of DAergic neurons [50]. This increased firing 
stimulates DA transmission in the mesolimbic pathway [48]. The mesolimbic pathway is 
a DAergic pathway that starts in the ventral tegmental area (VTA) and projects to the 
NAC, amygdala, hippocampus, and prefrontal cortex. Ethanol may decrease the activity 
of GABAergic interneurons in the mesolimbic pathway which would disinhibit the 
mesolimbic DA neurons to further increase DA release in the NAC shell [51]. 5-HT 
modulates DAergic activity in the VTA and NAC. Blockade of  5-HT3 with ICS 205-930 in 
rats prevents ethanol-induced increases of DA in the VTA [52] and NAC [53]. This 
suggests that ethanol increases DA release in the mesolimbic pathway by activating 5-
HT3. Furthermore, a nAChR antagonist, mecamylamine, blocks DA release in the NAC 
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when ethanol trained rats are presented with an ethanol-associated conditioned 
stimulus [28]. Antagonism of glycine receptors also decreases extracellular levels of DA 
in the NAC while agonism has the opposite effect [22]. Strychnine, an antagonist at both 
glycine and acetylcholine receptors, is capable of blocking the release of DA in the NAC 
caused by ethanol in male Wistar rats [23]. 
While dopamine levels are increased by ethanol administration, glutamate levels 
in the NAC have been shown to increase in response to a low dose of ethanol (0.5 g/kg) 
and decrease in response to a high dose (2.0 g/kg) of ethanol [54] suggesting that 
concentration dependent interactions between neuronal proteins and ethanol alter the 
response.  
There are many points of access for ethanol to affect DAergic signaling. Most of 
these access points have been shown to be direct targets of ethanol. A great deal of 
research supports the hypothesis that ethanol’s effects on DAergic signaling are 
important in its rewarding aspects and that this reward reinforcement is central to the 
development of dependence. For example, Wistar rats have been shown to self-
administer ethanol into the posterior VTA and this effect is blocked by quinpirole, a D2 
agonist. Further self-administration occurred when a D2 antagonist, sulpiride, was 
administered [55]. The results of these experiments strongly suggest that ethanol acting 
at D1-like receptors activates DAergic neurons in the VTA and this is necessary for the 
reinforcing effects. A particularly interesting study measured DA release in the NAC in 
high and low alcohol drinking (HAD/LAD) as well as alcohol preferring (AA) and alcohol 
avoiding (ANA) rats during their first exposure to ethanol. The researchers then 
monitored voluntary ethanol drinking for each rat over the course of 30 days and found 
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that increased DA release during the first exposure to ethanol was predictive of a higher 
preference for ethanol regardless of the strain of rat [56]. Taken together, it is clear that 
DAergic signaling is altered by ethanol’s actions at GABAA and 5-HT3 receptors and that 
this signaling is central to ethanol’s effects.  
 
5.4 Pharmacological and genetic modulation of ethanol responding 
From what is known about the targets of ethanol we can begin to understand 
how these interactions may effect neurotransmission. This section highlights 
pharmacological agents and knockout (KO) strains that alter ethanol responding and 
thus suggest a role for the target protein in the ethanol response.  
First, inverse agonists of GABAA, Ro 15-4513 and Ro 19-4603, reduce alcohol 
consumption in alcohol-preferring rats [57] which supports the hypothesis that GABAA’s 
disinhibition of DAergic neurons is required for the reinforcing effects of ethanol. 
Furthermore, KOs of GABAA subunits α1, α2, α5, and δ reduce alcohol consumption in 
mice [58]. This result not only supports the role of GABAA activation in ethanol 
reinforcement but also suggests the subunit composition of the pentameric channel that 
may be important in ethanol’s effects. The distribution of the subunits differ in the brain 
[59] and this may help to identify brain regions that are be affected by ethanol.  
Second, deletion of 5-HT transporters or blockade of 5-HT transporters by 
fluoxetine (which would increase synaptic 5-HT3) reduces alcohol self-administration in 
mice [60]. In agreement with 5-HT3 signaling having an inverse correlation with self-
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administration, overexpression of 5-HT3 receptors in mice has been shown to reduce 
alcohol self-administration [61]. 
Third, cholinergic signaling has been shown to be involved in voluntary alcohol 
consumption in both rats and mice. Mecamylamine, a nAChR antagonist, administered 
into the VTA reduced voluntary alcohol consumption in rats [62] while antagonism of 
α3β2*, β3*, and α6* containing nAChRs with α-conotoxin delivered to the VTA reduced 
voluntary alcohol consumption in both rats and mice [63]. Furthermore, crosstalk with 
the DAergic system was supported by the result that pretreatment with α-conotoxin 
reduced the release of DA in the NAC of mice [63]. 
Fourth, increase of extracellular glycine decreases both alcohol preference and 
intake in male Wistar rats. The glycine reuptake inhibitor Org 25935, which acts on 
glycine transporter 1, increases extracellular glycine which activates inhibitory 
strychnine-sensitive glycine receptors [24]. Systemic administration of Org 25935 
elevates NAC DA levels and prevents further increases in DA levels with ethanol 
administration [64]. Org 25935 blockage of ethanol-increased DA release may explain 
why, in the presence of elevated DA (due to Org 25935), voluntary ethanol consumption 
is decreased.  
These studies highlight the importance of cholinergic and glycinergic input onto 
DAergic signaling in the mesolimbic pathway in alcohol reinforcement. 
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5.5 Neurotransmitters in C. elegans 
Many neurotransmitters, enzymes, transporters and receptors involved in          
C. elegans neurotransmission have been identified.  This section briefly reviews some 
of the major neurotransmission pathways in C. elegans. 
5.5.1 Acetylcholine 
  Acetylcholine (ACh) was first found in Ascaris lumbricoides in 1957 [65] and was 
shown to be an excitatory neurotransmitter at NMJ by del Castillo et al. in 1963 [66]. 
Sydney Brenner, in his canonical C. elegans paper [67], reported the identification of 
mutants resistant to lannate, an acetylcholinesterase (AChE) inhibitor, and tetramisole, 
an AChR agonist. ACh in worms is synthesized by cha-1, the mammalian homolog of 
choline acetyltransferase (ChAT), from choline and acetyl-CoA [68]. C. elegans have at 
least 27 nAChR subunits [69] compared to 17 nAChR subunits in mammals. Similar to 
mammals, cessation of cholinergic signaling is accomplished by the metabolism of ACh 
to choline and acetate by any of several cholinesterases [70]. Cholinergic systems can 
be probed pharmacologically by the addition of aldicarb, an AChE inhibitor, or 
levamisole, an AChR agonist. Aldicarb inhibits the breakdown of acetylcholine in the 
synapse which in turn increases the signaling duration. Levamisole acts directly on the 
AChRs to activate the channel. Both of these compounds can be used to induce tonic 
paralysis caused by increased cholinergic signaling [71]. Strains that release more 
acetylcholine or have a higher expression of acetylcholine receptors will paralyze faster 
than wildtype when exposed to aldicarb or levamisole, respectively.  
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5.5.2 Dopamine  
Dopamine (DA) was first identified as a neurotransmitter in C. elegans by Sulston 
et al. in 1975 [72]. It was found to be important in modulating locomotion in response to 
mechanosensory input, including the slowing response to food [73]. For example, cat-2 
mutants cannot synthesize DA and do not slow in response to a lawn of E. coli [73]. DA 
has also been linked to state-dependent learning. Wild-type animals adapted to an 
odorant in the presence of ethanol exhibited adaptation to the odorant only if ethanol 
was again present during reexposure. If adapted animals were instead reexposed to the 
odorant in the absence of ethanol they responded to the odorant as if it were novel. cat-
1 and cat-2 mutants adapted to an odorant in the presence of ethanol showed 
adaptation regardless of whether ethanol was present during reexposure [74]. This 
demonstrated the necessity for DA in state-dependent learning. Four dopamine 
receptors have been found in C. elegans, DOP-1 through DOP-4. DOP-3 is a D2-like 
receptor that antagonizes the activity of the D1-like DOP-1 receptor [75]. Disinhibition of 
behaviors inhibited by ethanol are partially dependent on the D1-like DOP-4 receptor 
[19]. 
 
5.5.3 Serotonin  
Serotonin was first identified by Horvitz et al. in 1982 in C. elegans [76]. Like DA, 
it was also shown to be involved in the slowing response to food [73]. Worms stop in 
response to a bacterial lawn in order to eat. This stopping response requires 5-HT 
because mutations that disrupted serotonin signaling inhibited the full stop response of 
food deprived worms when they encountered a food source. Serotonin has also been 
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shown to modulate pharyngeal pumping rates [77]. Four serotonin receptors have been 
found; three metabotropic, SER-1, SER-4, and SER-7, and one serotonin-gated 
chloride channel, MOD-1 [78-81]. Beyond responses to food, serotonin has been shown 
to both stimulate and inhibit egg laying via the HSN neurons which has been 
hypothesized to cause the bursts of egg laying followed by a timeout period [82]. 
5.5.4 GABA 
GABA is an amino acid neurotransmitter synthesized via the decarboxylation of 
glutamate by glutamic acid decarboxylase. It was found to be active in C. elegans by 
Hedgecock in 1976 [83]. Twenty-six GABAergic neurons were identified by 
immunostaining for GABA [83]. The functions of these neurons were determined by 
laser ablation experiments in which each neuron was destroyed in turn using a precise 
laser and then phenotypes were assessed [84]. The ventral D-type GABAergic neurons 
were found to inhibit contraction of the dorsal and ventral body wall muscles allowing for 
sinusoidal movement. Mutants lacking D-type GABAergic neurons shrank when poked. 
The shrinking reaction was due to loss of contractile inhibition, or relaxation, leaving 
only the contraction [84]. Surprisingly, mutants lacking AVL and DVB lost the ability to 
stimulate the enteric muscles during defecation [84]. Thus the role of GABA to either 
stimulate or inhibit is based on the system it is acting in.  
 
5.5.5 Glutamate (Glu) 
Excluding neuromuscular transmission, most rapid excitatory synaptic 
transmission is mediated by glutamatergic signaling. At least 10 putative ionotropic Glu 
15 
 
receptor (iGluR) subunits are expressed in C. elegans [85, 86]. iGluRs are expressed in 
command interneurons that are responsible for forward and backward movement as 
well as nose poke reversals [85], RIA interneurons which are involved in thermotaxis 
[85, 87], and in the pharyngeal nervous system [85]. Genes encoding glutamate-gated 
chloride channels (GluCl) were identified in C. elegans by Cully et al. in 1994. These 
heteromeric channels are the channels that confer sensitivity to the anti-parasitic drug 
avermectin [88].  
5.5.6 Neuropeptides  
Beyond the classical neurotransmitters there are numerous small peptides that 
are involved in signaling in both mammals and C. elegans. Based on genomic analysis 
and some functional testing the number of predicted neuropeptides in C. elegans is well 
over one hundred [89]. A single gene encodes a pro-peptide that can release multiple 
peptides. Approximately 113 neuropeptide genes in C. elegans are expected to account 
for over 250 unique neuropeptides [90]. These peptides can be divided into two large 
families: insulin-like peptides and FMRF-like peptides (FLPs), the remaining non-insulin, 
non-FLP peptides are classified as neuropeptide-like proteins (NLPs). Neuropeptides 
are located in dense core vesicles which are derived from the trans-Golgi network. This 
is different from classical neurotransmitters that are in small vesicles clustered in 
synaptic zones. The processing of pro-peptides start in the endoplasmic reticulum with 
their cleavage into peptides and continues in the Golgi complex where the peptides are 
packaged into dense core vesicles and then transported to nerve terminals [90]. 
Neuropeptides in C. elegans can also act as hormones as shown by Sieburth et al. The 
group of researchers took advantage of the scavenger activity of the coelomocytes and 
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monitored release of GFP-tagged neuropeptide precursors into the pseudocoelom by 
the appearance of GFP in the coelomocytes [91]. Confirming a role for neuropeptide 
signaling in ethanol responding, mutation of NPR-1, the homolog to the mammalian 
neuropeptide Y receptor, increases the development of AFT to ethanol [92]. 
 
5.6 Level of response and AUDs 
While the propensity to develop alcoholism has been shown to be strongly 
genetically influenced [93], causative genes for AUD have also remained largely 
elusive. A large body of work spanning multiple decades has identified  a low level of 
response (LR) to ethanol as a predictive phenotype for increased likelihood of abuse 
[94]. Specifically, Marc Schuckit measured both the subjective high and the degree of 
sway in the response to alcohol in a group of 20 year old men. He found a high degree 
of variation in both responses. A decade later he grouped the men into those who 
developed alcoholism and those who did not. He found that the men who developed 
alcoholism reported lower subject highs and swayed less than the men who did not 
develop alcoholism. This work identified that LR was predictive of alcoholic outcomes 
[94]. Furthermore, a low LR at age 20 has been shown to increase the likelihood of 
alcoholism fourfold in both the sons of alcoholics and control groups [94].  Like AUDs, 
LR has also been shown to be heritable [95-98]. Taken together, these data suggest 
that the genes that are responsible for LR may also be central to the development of 
AUD, making them attractive targets for research. 
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5.7 Behavior as related to ethanol 
C. elegans exhibit numerous behaviors that are altered by intoxication and these 
aid in identification of ethanol responsive genes in forward genetic screens. Exogenous 
doses of ethanol ranging from 100-500 mM, of which approximately 5-10% accumulates 
[99], dose-dependently and reversibly decrease body bends, speed, and egg-laying of 
N2 worms on agar [39] while doses around 1 M reversibly inhibit locomotion in liquid 
[100]. These measures can be used to quantify the degree of intoxication, called the 
initial sensitivity, of treated strains compared to wild-type. Additionally, C. elegans 
develop acute functional tolerance (AFT) to ethanol over a 30 minute single exposure to 
ethanol. AFT is observed as an increase in speed from 10 minutes, the time point of 
maximum locomotor depression used to assess initial sensitivity, to 30 minutes. 
Furthermore, this has been shown to not be an effect of ethanol metabolism as internal 
ethanol concentrations increase slightly from 10 to 30 minutes [101]. Some behaviors 
observed on agar, such as foraging and reversals from touch, are inhibited when the 
worm is moved to a liquid environment. Recently, a 500 mM dose of ethanol was shown 
to disinhibit these behaviors in liquid [19]. These results show that both decreases and 
increases in behavior can be used to assess the response to ethanol in C. elegans. 
 
5.8 Alcohol and worms 
 Given that C. elegans become visibly intoxicated and develop tolerance to 
ethanol, genetic screens have been able to identified several mutations that alter this 
response.  
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Intoxication in C. elegans results in decreases in both locomotion and egglaying. 
Davies et al. found that mutations in slo-1, the gene encoding the nematode BK 
potassium channel, conferred resistance to ethanol induced decreases in both of these 
measures. Loss of BK channel activity resulted in hyperactive neurotransmission. The 
hyperactive neurotransmission mutants dgk-1 and goa-1 were not resistant to ethanol 
which confirmed that the resistance in slo-1 was not due to increased 
neurotransmission [39]. Rescuing constructs showed that neuronal SLO-1 was 
responsible for the resistance phenotype. Electrophysiological testing suggested that 
SLO-1 itself is a target of ethanol that is activated and leads to hyperpolarization of the 
neuron. This activation was also shown to be modulated by the lipid environment 
surrounding mouse SLO-1 in cell culture [39-41, 43, 45]. 
Clic4, an intracellular chloride channel, was identified as an ethanol regulated 
gene in microarray studies in mice and humans [102]. C. elegans has two Clic 
homologs, exl-1 and exc-4. Mutation of exl-1 conferred resistance and increased AFT, 
while mutation of exc-4 abolished AFT. Studies confirmed that changes in expression of 
Clic4 homologs also altered acute responses in mice and flies [102] suggesting the role 
of Clic4 in intoxication was conserved through multiple species. A mechanism of action 
for Clic4 in response to ethanol was not determined.  
RAB-3 is a neuronally expressed G protein that interacts with synaptic vesicles to 
modulate neurotransmitter release [103, 104]. RAB-3 mutants are resistant to aldicarb 
indicating that they release less acetylcholine than wild-type worms [104]. AEX-3 is a 
GDP exchange factor that interacts with RAB-3 [105]. RAB-3 mutants displayed 
resistance to 400 mM ethanol in both dispersal and locomotion assays. AEX-3 mutants 
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phenocopied RAB-3 indicating that RAB-3’s role in synaptic vesicle release was central 
to the resistance phenotype. These findings extended to a mouse model where Rab3A-
/- and Rab3A+/- mice had significant reductions in recovery time in LORR assays. 
Rab3A+/- mice also voluntary drank more of both 14% and 20% EtOH solutions. [106] 
npr-1 encodes a GPCR in the neuropeptide Y receptor family. Differences in 
NPR-1 activity in wild-type strains, N2 and CB4856, were shown to account for variation 
in social and feeding behavior [107]. Variation in ethanol response was also shown to 
correlate with NPR-1 activity. NPR-1 acts to antagonize the development of AFT. In 
CB4856 (carrying the low activity allele) and N2 carrying null-alleles of npr-1, AFT 
develops to a much higher degree than N2 (carrying the high activity allele) [101]. 
These results also extend to neuropeptide Y levels and mouse models of AFT in that 
signaling through the neuropeptide Y pathway opposes the development of AFT [108, 
109]. 
The mutations mentioned to this point were primarily in neuronal genes (SLO-1 is 
also expressed in muscle though its neuronal expression was found to be more 
important for intoxication). In a forward genetic screen, Bettinger et al. identified a 
mutation in the transcription factor ctbp-1 that resulted in decreased development of 
AFT. Further work identified lips-7, a triacylglyceride lipase under transcriptional 
regulation by ctbp-1, as having a central role in the modulation of AFT. Specifically, loss 
of lips-7 resulted in increased development of AFT and decreased initial sensitivity 
[110].  
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Loss of LIPS-7 was found to increase the levels of TAGs [111].Other mutations 
that altered fat storage and metabolism were found to also alter AFT. However, levels of 
fat storage did not simply correlate with changes in AFT. Investigation of membrane 
components found that cholesterol was necessary for the development of AFT [110]. 
These data suggested that the composition of the membrane altered the ethanol 
response. In support of this idea, a loss of lips-7 was able to rescue the locomotion of a 
slo-1 gain-of-function mutant suggesting that lips-7 interacts with SLO-1 and can alter 
its activity probably through changes in the lipid environment surrounding the channel. 
This result is in good agreement with findings that the lipid environment around various 
mammalian SLO-1 channels modulate their gating both basally and in response to 
ethanol [40, 41, 45]. An alternative or parallel hypothesis is that the loss of free fatty 
acids cleaved by lips-7 may alter the ethanol phenotype. However, the targets of LIPS-7 
are currently unknown and total lipid analysis has not consistently identified altered free 
fatty acid (FFA) levels. Of particular interest was the result that mutations in two 
desaturase genes (fat-7; fat-5) resulted in faster development of AFT. This suggested 
that the desaturation state of the lipids present in the worm played a crucial role in the 
development of AFT.  
KLF-3, a Kruppel-like transcription factor, that regulates fatty acid metabolism 
and lipid profile [112], is also involved in the development of AFT. Mutation of klf-3 
results in altered expression of numerous desaturase and elongase genes as well as 
increases in stearic and linolenic acids and a decrease in palmitic acid. Unfortunately, 
the lipid profile spectra did not adequately resolve polyunsaturated fatty acid (PUFA) 
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levels. [112]. A klf-3 mutant is also unable to develop AFT (citation in preparation). This 
supports another link between fatty acid metabolism and ethanol response.  
5.9 GxE interactions in alcohol abuse  
Research over the past decade has elucidated environmental risk factors that 
alter alcohol abuse liability through interactions with genetic predispositions. These 
gene-environmental interactions (GxE) are found when the expression of a gene or 
genotype differs across environments [113]. These studies are typically conducted 
using mono- or dizygotic twins that have been adopted into different households 
allowing researchers to separate the genetic and environmental factors that can lead to 
AUD. Alcohol-related outcomes, peers, positive alcohol expectancies, and drinking to 
cope with stress have all been shown to be mediators that interact with LR to influence 
abuse liability [96]. A large body of work exists on the GxE that influence AUD (for a 
review see [113]) and while these studies consider a large variety of psychological 
factors that influence behavior they do not consider diet as a factor that may modulate 
the development of AUD.  
It has been shown that lipids directly interact with and modulate known targets of 
ethanol, including the BK channels, and furthermore that the effects of ethanol on these 
targets can be modulated by the surrounding lipid environment [39-45, 110, 114-117]. 
Diet is an attractive target for research as it can be assessed and altered with minimal 
effort. Numerous studies have shown that lipid levels are altered by diet and that these 
changes can also have positive health outcomes for patients [118-126]. Recent work 
from our lab confirmed that altering triacylglyceride levels in C. elegans modulates the 
development of acute functional tolerance (AFT) [110].  
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5.10 Fatty acids 
5.10.1 Metabolism 
Much is known about fatty acid metabolism in C. elegans (Figure 1). 471 genes 
that are potentially involved in 16 lipid metabolic pathways have been identified [127].  
Of these 471 genes, 419 have human orthologs, which covers approximately 79% of 
the lipid metabolic genes in humans. This high degree of conservation in lipid 
metabolism makes C. elegans a good model organism to test the effects of FA 
metabolism on the response to ethanol [127]. Genes involved in the elongation and 
desaturation of fatty acids have been identified in worms (Figure 1). Furthermore, the 
lipid profiles of wild-type and mutant worms have been determined by thin-layer 
chromatography and gas-chromatography/mass spectrometry to better understand how 
mutations in the pathway alter the lipid profile [128-131]. Like mammals, C. elegans 
contain a wide array of saturated, monounsaturated, and polyunsaturated (sometimes 
further broken down into poly- and highly unsaturated) fatty acids. While most of the 
elongases and desaturases in C. elegans are conserved in mammals there are a few 
notable exceptions:  (1) While mammals can synthesize low levels of EPA and DHA 
from ALA, C. elegans is able to efficiently synthesize omega-3 fatty acids from omega-6 
precursors by the action of the omega-3 desaturase FAT-1 which mammals do not 
have, and (2) C. elegans do not synthesize detectable levels of docosahexaenoic acid 
(DHA) or any fatty acids with carbon chains greater than 20 [132]. Regardless of these 
changes, dietary supplementation of fatty acids as well as polymorphisms in lipogenic 
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genes have been shown to affect the fatty acid profiles of both mammals and C. 
elegans [131, 133, 134]. 
 
5.10.2 Roles of fatty acids  
Fatty acids have numerous roles beyond energy storage in TAGs. Fatty acids 
compose the lipid bilayer of each cell, interact with membrane bound proteins to 
modulate their function (e.g. in neurotransmission), can act as signaling molecules or 
precursors to signaling molecules, or as regulators of gene transcription. For the work 
presented in the next chapters, three of these roles are of particular interest: (1) 
modulation of synaptic vesicle release, (2) direct and indirect signaling (both as free 
fatty acids and as precursor molecules), and (3) gene regulation.  
Figure 1. Fatty acid metabolism in C. elegans. Elongases and desaturases, in the blue 
boxes, catalyze the conversion of fatty acid species per the arrow they are next.  
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5.10.2.1 Synaptic vesicle release 
Some of the first mutants identified by Sydney Brenner had mutations in 
cholinergic genes that altered the sensitivities to acetylcholine receptor agonists and 
acetylcholinesterase inhibitors [67]. While the pharmacological agents in popular use 
have changed since then, assessing cholinergic activity by means of agonists and 
acetylcholinesterase inhibitors is still in use [71]. Given that long acyl chain PUFAs are 
often highly enriched in synaptic membranes [135, 136] it is not surprising that 
mutations of genes in the PUFA pathway can cause neuronal and behavioral disorders 
in humans and C. elegans [137, 138]. Watts and Browse found a mutation in the FAT-3 
desaturase gene that resulted in a complete loss of long chain PUFAs (LC-PUFAs) 
[130]. Work done shortly afterwards by Lesa et al. determined that these mutants were 
slower, laid fewer eggs, and were resistant to the paralyzing effects of aldicarb which 
suggested that they were deficient in cholinergic neurotransmission. Furthermore, they 
showed that these phenotypes were rescued by exogenous treatment with arachidonic 
acid (AA) and docosahexaenoic acid (DHA). Electrophysiological studies showed that 
fat-3 mutants were releasing fewer synaptic vesicles than wild-type worms and 
presynaptic sites were depleted of synaptic vesicles suggesting a deficiency in vesicle 
formation or recycling [117]. Follow-up work by Marza et al. determined that 
synaptojanin localization was dependent on LC-PUFAs.  
It is important to note that the rescue of fat-3 phenotypes by DHA may not have 
been directly attributable to DHA or any of the signaling molecules it could be a 
precursor for. While Lesa et al. did not observe an increase in EPA levels in fat-3 worms 
treated with DHA, in a separate fatty acid supplementation experiment Hillyard and 
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German did see a small but significant increase in EPA levels when these worms were 
treated with DHA [132]. While the conversion of DHA to EPA has not been shown, but 
beta oxidation would be capable of shortening DHA to 20 carbons (DHA is 22 carbons 
and EPA is 20 carbons). Likewise, saturation of PUFAs has been noted before as EPA 
treatment in fat-3 has been shown to cause a slight increase in omega-3 arachidonic 
acid (O3AA). This saturation pathway is probably not observed in wild-type animals due 
to the presence of both substrate (e.g. AA) and product keeping the reaction at 
equilibrium (e.g. EPA). Only when EPA is abundant and its precursor O3AA is absent 
does the reverse reaction occur in normal lab conditions. This suggests that small 
amounts of EPA may have been responsible for the rescue observed in the Lesa et al. 
paper. An alternative hypothesis is that DHA is structurally substituting for a PUFA that 
is normally present in the worm that allows for the modulation of membrane bound 
proteins. If EPA is acting as a precursor to a signaling molecule then the possibility 
exists that DHA may also be a precursor to a similar or the same signaling molecule. 
While unlikely, the DHA preparation could have been contaminated with low but 
sufficient levels of EPA.  
Once synaptic vesicles have fused with the synaptic membrane and released 
their cargo of neurotransmitters the lipids and proteins that made up the vesicle diffuse 
into the synaptic membrane. These lipids and proteins are recycled to form new 
synaptic vesicles [139]. Synaptojanin is responsible for the dephosphorylation of 
phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2], a phosphoinositide that is 
anchored to the membrane by a LC-PUFA, which decreases the affinity of clathrin 
adaptor proteins for the membrane and is an essential step for endocytosis of synaptic 
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vesicle membrane and proteins [140]. LC-PUFAs are also enriched in synaptic vesicles 
and are partially responsible for their high degree of curvature [141]. Marza et al. 
confirmed that LC-PUFAs were necessary for proper localization of synaptojanin at 
release sites in C. elegans. Loss of LC-PUFAs also resulted in an accumulation of 
PtdIns(4,5)P2 in the presynaptic membrane, a reduction in synaptic vesicles, and an 
increase in the size of the synaptic vesicle (due to a reduction in the curvature of the 
vesicle). Dietary supplementation of LC-PUFAs was also shown to be sufficient to 
rescue synaptojanin localization and the signaling deficiencies [142].  
 
5.10.2.2 Lipid signaling 
Lipids are involved in signaling both directly as signaling molecules and as 
precursors to signaling molecules. These molecules include eicosanoids, 
lysophospholipids, sphingolipids, and endocannabinoids. Lipid signaling pathways are 
recognized as major components of many cellular processes, most notably for their role 
in immune and injury responses. Their role in drug addiction is less well understood but 
has been demonstrated [143, 144]. Lipid transmitter signaling has already been 
suggested as a target of research for the alcohol and cocaine communities [143] as well 
as being a possible target to treat cocaine addiction [144]. 
In mammals, lipid transmitters fall into three major classes: (1) AA-derived 
eicosanoids, (2) lysophospholipids and their derivatives, and (3) newly discovered lipid 
transmitters that are derived from omega-3 fatty acids [145]. These general classes help 
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to simplify the very complicated pathways that exist in the creation and signaling of 
lipids. 
 
5.10.2.2.1 Class 1: AA-derived eicosanoids 
 Many of the most well-known lipid transmitters fall into the first class. These 
include prostaglandins, leukotrienes and their relatives. After its release from the 
membrane, AA is converted to PGG2 and then to PGH2 by cyclooxygenases (COX) and 
then further converted to five major signaling molecules (PGE2, PGD2, PGF2α, PGI2, 
TXA2 PGE2) by prostaglandin synthases [145]. PGE2 is the most studied of the group 
for its roles in inflammation, fever, pain, and cancer through its receptors EP1 to EP4 
[146]. Eicosanoids synthesized by COX have been a major focus for the treatment of 
pain through the use of non-steroidal anti-inflammatory drugs (NSAIDs) [147].  
Leukotriene (LT) synthesis is similar to PG synthesis. After release from the 
membrane, AA is converted to the unstable intermediate LTA4 by 5-LOX and then 
converted to either LTC4 or LTB4 by LTA4 hydrolase or LTC4 synthase, respectively 
[145]. LTs are central to the asthmatic response and mice deficient in LT synthesis are 
resistant to asthmatic challenge [148].  
 
5.10.2.2.2 Class 2: Lysophospholipids and derivatives  
Class 2 lipid transmitters include platelet-activating factor (PAF), 
lysophosphatidic acid (LPA), sphingosine-1-phosphate (S1P), ceramide-1-phosphate 
(C1P), and the endocannabinoids. PAF was the first of the lysophospholipid derived 
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transmitters that was discovered. Knockout studies of the PAF receptor in mice have 
suggested that PAF is involved in inflammation and allergy response [149]. LPA has 
been shown to have a role in both brain and cardiovascular development in mice and 
humans [150] indicating that these lipid transmitters are involved in both acute response 
and developmental pathways. S1P and C1P were found to have unique roles in the lipid 
signaling pathways. S1P induces COX-2 [151] and C1P activates PLA2 in the Golgi 
membrane [151]. This highlights the crosstalk between various lipid signaling pathways 
and further complicates targeting of the pathways by pharmacological interventions. The 
endocannabinoids are nearly a class unto themselves but due to structurally similarity 
fall under class 2. The N-acetylethanolamine (NAE) anandamide and 2-
arachidonoylglycerol (2-AG) are the best characterized endocannabinoids. They have 
been shown to mediate anti-nociceptive and anti-inflammatory effects through 
interactions with CB1 and CB2 receptors [152, 153]. Inhibition of monoacylglycerol 
lipase and fatty acid amide hydrolase has been used to increase levels of 2-AG and 
anadamide, respectively, and have been of particular interest in the treatment of chronic 
pain after many exogenous cannabinoids showed abuse liability [154].  
5.10.2.2.3  
5.10.2.2.4 Class 3: Omega-3 derived lipid mediators 
The newest class of lipid transmitters, studied most extensively in mammals, are 
the resolvins, protectins, maersins, and lipoxins that are all involved in resolving 
inflammation. Lipoxin, although it falls into this class based on its involvement in 
inflammation, is actually derived from AA. The remaining lipid transmitters are derived 
from omega-3 fatty acids via conversion by 12/15-LOX and other unidentified enzymes. 
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Although the enzymes have not been identified, EPA and DHA are the known 
precursors for resolvins and proctectins, respectively [155, 156]. Whereas before 
omega-3 fatty acids were thought to be anti-inflammatory through their competition with 
AA for COX conversion to pro-inflammatory eicosanoids, now data exists that these 
LOX derived signaling molecules also act to resolve inflammation rather than only 
interfere with its formation [156]. 
Work over the past decade has found that numerous orphan mammalian GPCRs 
respond to various chain length fatty acids. These receptors have been deemed free 
fatty acid receptors (FFARs). FFARs act as physiological sensors for the intake of 
dietary free fatty acids and regulate energy metabolism through the modulation of 
insulin secretion. This means that free fatty acids by themselves can also be considered 
as a class of lipid transmitters. FFARs are now the target of investigations pertaining to 
the treatment of type 2 diabetes and offer an intriguing new view for free fatty acids in 
signaling [157]. 
Discoveries of lipid signaling pathways have been noticeably slower than protein 
based signaling molecules. This is in part due to signaling fatty acids being masked by 
the large steady-state mass of structural lipids in membranes [145]. While some of the 
enzymes that convert free fatty acids to signaling molecules have been identified and 
can be found in the genome, free fatty acids that require no conversion have no direct 
genome encoding proteins to alter their function. This further increases the difficulty in 
targeting these pathways for study and pharmacological intervention. However the 
receptor or the fatty acid itself can still be targeted.  
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5.10.2.3 Gene regulation by lipids  
In 1992 Gottlicher et al. established the existence of nuclear receptors that bound 
fatty acids [158]. Nuclear receptors bind to nuclear response elements within the 
promoter regions of genes to affect their transcription. These response elements are 
encoded by direct, everted or inverted repeats (DR, ER, and IR, respectively) with a 
variable number of nucleic acid “spacers” between the repeats. For example, AATTGG-
ATG-GGTTAA would be an inverted repeat with three nucleic acids between the 
repeats and its shorthand would be IR3.  
PUFAs have been shown to regulate numerous lipogenic genes both in 
mammals [159] and in cell culture [160]. Furthermore, this effect has been shown to 
work within hours of feeding PUFAs through observed decreases in S14 gene 
transcription and abundance of mRNA in hepatic tissue [161]. Regulation can occur in a 
tissue specific manner which could be advantageous for targeted therapies. In general, 
PUFAs increase genes responsible for β-oxidation and decrease expression of 
lipogenic genes [162]. PUFAs have been demonstrated to interact with at least three 
nuclear receptors: hepatic nuclear factors (HNF)-4α, liver X receptors (LXRs) α and β, 
and peroxisome proliferator-activated receptors (PPARs) α, β, and γ [163].  
Fatty acyl CoA thioesters bind to HNF-4α and can either activate or inhibit the 
receptor depending on the chain length of the lipid [164]. When activated, HNF-4α binds 
to DR1 sequences as homodimers [165]. It’s believed that PUFAs are inhibitory to HNF-
4α and disrupt its ability to bind to its recognition site [166]. 
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Peroxisome proliferator-activated receptors (PPARs) dimerize with retinoid X 
receptors (RXRs) and bind DR1 peroxisome proliferator response elements (PPREs) 
[167]. To test their ability to bind PUFAs, Gottlicher et al. used a chimeric construct 
consisting of the ligand-binding domain of rat PPAR and the DNA-binding domains of 
the human glucocorticoid receptor. This construct was expressed in CHO cells with a 
gene for alkaline phosphatase under the control of the mouse mammary tumor virus 
promoter as a reporter for receptor activation. Phosphatase activity was assessed 
spectrophotometrically. Phosphatase activity was inducible by linoleic and arachidonic 
acids but not by steroid hormones or sterols (DHEA, cholesterol or 25-OH-cholesterol). 
Furthermore, the activation by linoleic and arachidonic acids were dose-dependent 
suggesting that the regulation of transcription can be fine-tuned based on dietary intake 
of these free fatty acids [158]. 
Cellular cholesterol and fatty acid metabolism in mammals is controlled by a 
family of transcription factors called sterol regulatory element-binding proteins (SREBP). 
In sterol-deficient cells, cleavage of SREBP from the Golgi membrane results in its 
transit to the nucleus, binding to sterol response elements (SRE), and the transcription 
of lipogenic genes to increase cholesterol, triglyceride, and fatty acid biosynthesis [168]. 
SREBP1c gene expression is induced by cholesterol and repressed by PUFAs. In a 
high cholesterol and high PUFA diet, cholesterol was still able to increase SREBP1c 
mRNA and protein levels, however levels of the mature, cleaved protein were repressed 
as were the genes normally activated by SREBP1c binding. These results suggest that 
PUFAs regulate SREBP1c activity through opposing the maturation of the protein and 
not its transcription or translation [169]. 
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LXRs bind oxysterols and heterodimerize with retinoid X receptor (RXR)α. They 
then bind DR4 sequences (known as LXR response elements [LXREs]) [170], and 
regulate fatty acid and cholesterol transport and metabolism [171]. Regulation by LXRs 
is accomplished through activating the SREBP1c gene promoter [172]. Genes regulated 
in this manner include fatty acid synthase (FAS) and acetyl CoA carboxylase (ACC) 
[173] which are the first two enzymes in fatty acid elongation in C. elegans (Figure 1) 
[174]. Although the mechanism is not known, PUFAs block LXR gene regulation 
possibly by inhibiting the binding of LXR to RXR [175]. 
 
5.10.2.4 Lipid modification of proteins 
Palmitoylation, or S-acylation, is the reversible addition of an activated fatty acid, 
usually palmitic acid, to a cysteine residue of a protein by a thioester bond. This linkage 
Figure 2. Palmitoylation has been shown to affect protein trafficking through the Golgi 
network, trafficking to the membrane, localization within the membrane, activity, 
internalization and subsequent recycling or degradation.  
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is achieved by the action of a palmitoyltransferase and can be reversed by a 
thioesterase. While not much is known about the specificity of palmitoyltransferases for 
their targets, many ion channels have been shown to be palmitoylated. Of particular 
interest are GABAA, NMDA, and BK channels, all known targets of ethanol, all of which 
are palmitoylated [176-181]. Palmitoylation has been shown to affect trafficking of 
channels between the endoplasmic reticulum, Golgi, and the plasma membrane as well 
as the localization within the membrane, the activity of some channels, as well as 
modulating the internalization and subsequent recycling or degradation (Figure 2) [182]. 
Most proteins that have been shown to be palmitoylated contain multiple palmitoylation 
sites with each modulating an individual process. 
5.11 C. elegans eicosanoid production 
In mammals, CYP-dependent eicosanoids such as EETs and 20-HETEs 
modulate the activity of various ion channels including BK channels [183, 184], L-type 
calcium channels [185], and TRPV channels [186]. 17(R),18(S)-EETeTR acts as a 
highly potent activator or vascular smooth muscle BK channels [184].  
Eicosanoid signaling in C. elegans is less well understood than in mammals. 
However, it has been shown that AA and EPA are both metabolized to epoxy and 
hydroxy derivatives that are known to be signaling molecules in mammals. Specifically, 
CYP-29A3 and CYP-33E2 are the major P450 enzymes responsible for the metabolism 
of EPA and AA [187]. With 75 cytochrome P450 genes in the genome of C. elegans, it 
is possible that these additional enzymes also act in lipid signaling pathways [187]. 
CYP-35A2, CYP-35A3, CYP-35A4, CYP-35A5, and CYP-35B1 have been shown to 
alter fat storage pathways in the nematode [188, 189]. Given the numerous possible 
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roles for lipids (e.g., signaling, structural, gene regulation) these P450s may also play 
an indirect role in signaling. C. elegans has no obvious orthologs of mammalian COX 
and LOX enzymes as well as no obvious PG or LT receptors [117]. This suggests that 
while lipid signaling may occur through P450 dependent pathways more work will need 
to be done to identify the enzymes, molecules and receptors. Additionally, eicosanoid 
signaling in C. elegans may rely more heavily on EPA as it is the predominant lipid 
species in the worm [130] as compared to AA in humans [134]. The lack of longer chain 
fatty acids in C. elegans also precludes the use of DHA as a signaling molecule and 
precursor. Given that different PUFAs are enriched in synaptic membranes between C. 
elegans (EPA) and humans (DHA) their roles may be similar but accomplished through 
different pathways. To this end, Kulas et al. noted that while the mammalian homologs 
of CYP-29A3 and CYP-33E can be distinguished as AA hydroxylases and AA 
epoxygenases that the C. elegans isoforms have the ability to catalyze both reaction 
types when converting EPA [187].  
Given the diverging functions of these homologs, Kulas et al. tested the ability to 
block EPA and AA metabolism with 17-ODYA, PPOH, and CO. These inhibitors of 
mammalian P450 enzymes potently inhibited C. elegans metabolism of EPA and AA in 
a microsomal preparation. Also similar to mammalian eicosanoid signaling, the 
derivatives were increased by treatment with the PPARα activator, fenofibrate. A 
homology search for human homologs of CYP-29A3 and CYP-33E2 found that CYP-
29A3 was similar to the family of CYP4 enzymes and CYP-33E2 was similar to the 
CYP2 family of enzymes. While no function was assigned to any of the lipid derivatives 
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detected in their work, Kulas et al. did conclude that the metabolites are endogenous 
constituents of C. elegans with functions to be determined.  
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6 Eicosapentaenoic Acid Necessary for the Development of AFT 
6.1 Introduction 
6.1.1 Alcohol use and abuse 
Alcohol abuse disorders affect approximately eighteen million Americans and are 
estimated to cost the United States $223.5 billion, or 2% of its GDP each year [1, 2]. 
Current pharmacological interventions are inadequate, which is due, in part, to the 
complexity of alcohol’s molecular effects. The propensity to develop alcoholism is 
strongly genetically influenced [93]. However, due to these complex molecular effects 
and despite intense study, few candidate genes for alcoholism have been identified.  
 
6.1.2 Genetic and environmental influences on alcoholism 
While causative genes for alcohol abuse disorders (AUD) have remained largely 
elusive, a large body of work spanning multiple decades has identified  a low level of 
response (LR) to ethanol as an phenotype of alcohol use disorders [94]. A person’s 
level of response has been typically assessed by body sway, subjective high, and 
cognitive testing within a single drinking session. A low LR at age 20 has been shown to 
increase the likelihood of alcoholism fourfold in both the sons of alcoholics and control 
groups [94]. Furthermore, LR has been shown to be heritable [95-98]. Taken together 
these data suggest that the genes that are responsible for LR may also be central to the 
development of AUD, making them particularly attractive targets for research. 
Additionally, work over the past decade has elucidated environmental risk factors that 
alter alcohol abuse liability through interactions with genetic predispositions. These 
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gene-environmental interactions (GxE) are found when the expression of a gene or 
genotype differs across environments [113]. These studies are typically conducted 
using mono- or dizygotic twins that have been adopted into different households. This 
allows the researchers to separate the genetic and environmental factors that can lead 
to alcohol abuse disorders. Alcohol-related outcomes, peers, positive alcohol 
expectancies, and drinking to cope with stress have all been shown to be mediators that 
interact with LR to influence abuse liability [96]. A large body of work exists on the GxE 
that influence AUD (for a review see [113]) and while these studies consider a large 
variety of psychological factors that influence behavior they do not consider the possible 
role of diet modulating the development of AUD. It has been shown that lipids directly 
interact with and modulate known targets of ethanol, including the BK and TRPV 
channels, and furthermore that the effects of ethanol on these targets can be modulated 
by the surrounding lipid environment [39-45, 110, 114-117]. Diet is an attractive target 
for research as it can be assessed and altered with minimal effort. Numerous studies 
have shown that not only can lipid levels be altered by diet but that these changes can 
also have positive health outcomes for the patients [118-126]. Recent work from our lab 
confirmed that altering triacylglyceride levels in C. elegans modulates the development 
of acute functional tolerance (AFT) [110]. With this in mind, we have assessed the role 
of long-chain polyunsaturated fatty acids (LC-PUFA) on initial sensitivity and 
development of AFT in C. elegans.  
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6.1.3 C. elegans as a model organism 
 Caenorhabditis elegans provides a simple system to study the genetic and 
molecular effects of ethanol intoxication and LR. Intoxication in C. elegans occurs at 
doses that cause intoxication in other organisms [99, 190, 191]. Genes identified in the 
worm that alter ethanol response, when they have been tested, also modify ethanol 
responses in rodents [192]. These observations suggest a conserved mechanism for 
ethanol responses between C. elegans and mammals. This initial response to ethanol is 
composed of at least two components [191] that can be assessed experimentally in C. 
elegans: initial sensitivity and AFT. Initial sensitivity corresponds to the magnitude of 
intoxication at its maximum effect and is observed in C. elegans as the maximum loss of 
speed at ten minutes of ethanol exposure. AFT is predicted to be the summation of 
homeostatic neuronal mechanisms that adapt to the intoxicating effects of a single dose 
of ethanol, and in humans is observed as the recovery in behavioral impairment over 
the course of a single drinking bout at the same or higher blood alcohol concentrations 
[94]. In C. elegans, AFT is measured as a recovery in locomotion between the ten and 
thirty minute time points of an ethanol exposure assay. Over this time period the worms’ 
speed increases as does the tissue concentration of ethanol [99], demonstrating that 
AFT is neither due to metabolism nor a change in the pharmacokinetics of ethanol over 
the course of the assay. Previous work has shown that the effects of ethanol in C. 
elegans are largely neuronal in nature and that initial sensitivity and AFT are dependent 
on proper neuronal expression of ethanol targets [39].  
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 Mutations that affect fatty acid metabolism in humans have been shown to have 
neurological consequences. Specifically, mutations in ELOVL4 and FACL4 can cause 
macular degeneration and nonspecific X-linked mental retardation, respectively [137, 
138]. This is perhaps not surprising given the enrichment of long chain polyunsaturated 
fatty acids (LC-PUFA) in the brain and retina [193, 194]. Their importance is further 
stressed by their near absence in adipose tissue [195]. Mutations that alter fatty acid 
metabolism in worms have also been shown to negatively affect synaptic vesicle 
recycling and neurotransmitter release [117, 142]. These same mutations, as well as 
many others in the fatty acid metabolic pathway, have been well characterized both in 
their effects on lipid profiles and behavioral phenotypes [116, 117, 128-130, 174, 196, 
197]. By using these mutations in various desaturases and elongases, specific fatty 
acids can be altered to ascertain their roles in the response to acute ethanol.  
 
Mutants that lacked polyunsaturated fatty acids (PUFAs) were unable to develop 
AFT and were more sensitive to the intoxicating effects of ethanol. Furthermore, we 
identified eicosapentaenoic acid (EPA) as the main fatty acid that is necessary for the 
development of AFT. Additionally arachidonic acid (AA) is capable of rescuing AFT only 
if fat-1 is wild-type and can convert AA to EPA. This rescue was shown to be possible in 
as little as 19 hours of treatment. Paralysis assays with an acetylcholinesterase inhibitor 
suggested that the rescue of AFT was not correlated with the rescue of cholinergic 
signaling. These results indicate a yet undefined role for EPA.  
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6.2 Material and methods 
6.2.1 Culture 
Unless otherwise noted, strains were maintained on nematode growth media 
(NGM) plates at 20°C . Before use, NGM plates were seeded with OP50 E. coli and a 
lawn of bacteria was allowed to grow overnight at room temperature. 
 
6.2.2 Strains 
The wild type strain used was N2 (var Bristol). Mutant strains used were: BX24 
fat-1(wa9), BX17 fat-4(wa14), BX30 fat-3(wa22). 
 
6.2.3 Locomotion tracking 
Speed was analyzed as described previously [101] with minor changes: Assay 
plates were dried for one hour at 37°C with the lids removed. Four copper rings were 
heated and melted into the surface of the plates. Ice-cold 100% ethanol was added to a 
final concentration in agar of 0 mM or 400 mM. Plates were immediately sealed with 
Parafilm and the ethanol was left to absorb into the plate for two hours at room 
temperature. Age-matched first day adults were acclimated by moving them to 
unseeded plates with copper rings for thirty minutes. At thirty minutes ten worms of 
each strain were then moved from acclimation plates to the corresponding copper ring 
on the assay plate. The first ten minutes of exposure as well as the two minutes 
following the thirty minute time point were recorded for each plate. Movies were made 
on an Leica MZ6 stereo microscope with a 0.5x objective and 0.8x magnification using a 
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Retiga 4000R camera (QImaging) and ImagePro Plus (6.2) (MediaCybernetics) 
software. Recordings were made at one frame per second and the speed of each worm 
was tracked using ImagePro Plus software. The average speed for each group was 
calculated and treated as a single trial. All strains were tested a minimum of five times. 
 
6.2.4 Fatty acid supplementation 
Fatty acid salts (Nu-Chek Prep, Elysian, MN) were diluted to 20 mM in dH2O. 
NGM solutions were prepared with the addition of 0.1% NP-40 (Sigma) and autoclaved. 
The NGM solutions were held in a 60°C water bath for one hour. EPA or AA was added 
to a final concentration of 160 µM, control plates were supplemented with an equal 
volume of water. Plates were poured immediately and dried overnight at room 
temperature in a dark box. Plates were seeded the following day and stored at 20°C for 
48 hours before use [116].  
 
6.2.5 Age synchronization 
Egg laying: Adult worms were allowed to lay eggs for two hours on seeded NGM 
or fatty acid supplemented plates. The adults were then removed. The eggs were 
allowed to hatch and develop to first day adults before assaying.  
 
6.2.6 Assessment of ethanol response 
A relative speed for each time point is calculated by dividing the treated speed by 
the untreated speed within a genotype. We assess initial sensitivity by comparing the 
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ten minute relative speeds between strains. A statistical difference in the speeds reflects 
a significant change in the initial sensitivity. We next compare the ten and thirty minute 
relative speeds within a strain to determine if AFT has developed. A statistically 
significant increase in the relative speed at thirty minutes is AFT. Lastly, we compare 
the degree of AFT between strains. AFT is quantified as percent recovery of speed and 
is calculated by subtracting the ten minute relative speed from the thirty minute relative 
speed. A statistically significant difference between strains’ percent recovery reflects a 
significant difference in AFT.  
 
6.2.7 Statistics 
Animals that were compared to each other were treated on the same plate at the 
same time under identical conditions. Data were converted to relative speeds to account 
for basal speed differences between strains. Statistics were performed using Prism 5.0 
(GraphPad). For comparisons of a single strain or treatment to a control, two-tail paired 
t-tests were performed. When multiple comparisons were necessary, as in the fatty acid 
supplementation assays, one-way ANOVA with a Dunnett’s post hoc test was used. 
Aldicarb assays were analyzed by two-way ANOVA with a Bonferroni post-hoc test.  
6.2.8 Aldicarb assay 
Plates containing 1 mM aldicarb (Sigma) were prepared fresh for each set of 
paralysis assays as described previously [71]. Twenty adult animals were scored per 
experiment and three independent experiments were carried out [198]. Worms were 
counted as paralyzed if they were unable to respond to any of three pokes with a 
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platinum wire on the head and tail. Statistical analysis was performed using Prism 5.0 
(GraphPad). 
 
6.3 Results 
6.3.1 LC-PUFAs are necessary for the development of AFT 
We began by asking if LC-PUFAs had a role in the development of AFT. To test 
this we exposed fat-3(wa22) mutants, which lack all LC-PUFAs, to 400 mM ethanol and 
assessed their locomotion over time. We found that fat-3(wa22) mutants were unable to 
develop AFT and were more sensitive to the intoxicating effects of acute ethanol (Figure 
3A). These data suggested that one or more of the LC-PUFAs were necessary for the 
molecular mechanisms that compensate for acute intoxication. We next asked which of 
the LC-PUFAs were necessary for the development of AFT. To test this we repeated 
our 400 mM ethanol assay with fat-1(wa9) and fat-4(wa14) mutants which lack two LC-
PUFAs each, EPA and omega-3 arachidonic acid (O3AA) in fat-1 and EPA and AA in 
fat-4. Our results showed that both mutants displayed near wild-type initial sensitivity 
and that both were unable to develop AFT (Figure 3B). Taken together with the fat-3 
result these data suggest that initial sensitivity is likely affected by linoleic acid (LA), and 
dihomo-γ-linolenic acid (DGLA) and furthermore either that O3AA and AA must both be 
present for the development of AFT or that EPA, the LC-PUFA lost in both mutants, is 
necessary for AFT.  
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6.3.2 Fatty acid supplementation is capable of rescuing AFT 
 Dietary supplementation of PUFAs is capable of rescuing affected levels of 
PUFAs as well as phenotypes associated with their loss [116, 117, 131, 142]. 
Consistent with these reports, we found that basal speeds of fat-1(wa9), fat-4(wa14), 
and fat-3(wa22) could be rescued by fatty acid supplementation (Figure 6). In order to 
confirm that supplementation is capable of rescuing the AFT phenotype we first 
supplemented AA into the diet of fat-4(wa14) worms in order to restore AA and EPA 
(through the desaturation of AA to EPA by FAT-1). Raising fat-4(wa14) worms on NGM 
supplemented with 160 µM AA resulted in recovery of AFT to wild-type levels. AA also 
did not have a significant effect on the development of AFT in wild-type (Figure 4A). 
These results suggested that PUFA supplementation was capable of rescuing AFT and 
further suggested that AA and EPA were sufficient for the development of AFT. This 
result allowed us to ask if EPA would be sufficient to rescue AFT in fat-4(wa14) or, 
conversely, if AA was necessary in the presence of EPA. EPA supplementation of fat-
4(wa14) resulted in the robust development of AFT to wild-type levels (Figure 4B). 
While EPA did not have a statistically significant effect on wild-type in these assays it 
did tend to increase the development of AFT. However, EPA supplemented fat-4(wa14) 
AFT was statistically not different from EPA supplemented wild-type AFT. These results 
suggested that AA was not necessary for the development of AFT in the fat-4(wa14) 
background and that EPA alone was sufficient.  
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6.3.3 EPA and not AA is necessary and sufficient for the development of AFT 
 In order to further differentiate between the roles of AA and EPA we 
supplemented each LC-PUFA into fat-1(wa9), which is unable to convert AA to EPA and 
DGLA to O3AA and thus lacks both EPA and O3AA. Supplementation of AA into the fat-
1(wa9) background resulted in no significant development of AFT (Figure 4C). This 
suggested that AA was only capable of rescuing AFT when it could be further converted 
to EPA. EPA supplementation of fat-1(wa9) rescued AFT back to wild-type levels 
(Figure 4D), ensuring that EPA was still sufficient to rescue AFT in this background. 
These results also suggest that O3AA is not necessary and increased levels of AA do 
not result in a loss of AFT.   
 To further test sufficiency of EPA in the development of tolerance we 
supplemented it into the diets of fat-3(wa22) worms. This supplementation has been 
shown to result in the significant rescue of EPA levels while not affecting the loss of 
GLA, DGLA, and AA, and O3AA [116]. EPA alone was able to rescue the development 
of AFT but not restore it to wild-type levels (Figure 4F). This suggested that EPA in 
conjunction with upstream fatty acids are responsible for robust development of AFT or 
that the loss of LC-PUFAs in fat-3 results in further defects that affect our assay and are 
unable to be rescued by EPA alone. Supplementation of AA into the diets of fat-3(wa22) 
worms, increasing both AA and EPA levels, resulted in wild-type levels of AFT 
developing (Figure 4E). Taken together these results suggest that EPA is necessary for 
the development of AFT but that it also works in conjunction with other upstream LC-
PUFAs.  
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6.3.4 Wild-type AFT can be modulated by fatty acid supplementation 
The increased development of AFT in N2 from both AA and EPA 
supplementation was never significantly different from N2 within a set of experiments. 
When the data was compiled a small but significant increase in initial sensitivity was 
observed from the AA supplementation and a significant increase in AFT was observed 
for both LC-PUFAs (Figure 5). These results suggested that the intact molecular 
pathways involved in the development of AFT via LC-PUFAs could be further modulated 
through dietary supplementation.  
6.3.5 Rescue of basal speeds and AFT by EPA are separable 
 fat-1(wa9), fat-4(wa14), and fat-3(wa22) are significantly slower than N2 and their 
speeds are rescued by rearing the worms on 160 µM EPA (Figure 6). In determining the 
time course of supplementation necessary for the rescue of AFT we found that 19 hours 
of EPA supplementation was sufficient to rescue AFT but not basal speeds in fat-1(wa9) 
(Figure 7). This suggested that the reduction in basal speed was a defect that required 
supplementation likely throughout development while the loss of AFT could be rescued 
by supplementation only during the L4 to adult timeframe. The separation of basal 
speed and AFT rescue also suggests that differences in basal speed did not account for 
the loss of AFT.  
6.3.6 Cholinergic signaling does not correlate with AFT rescue 
 While these data show that EPA is both necessary and sufficient for the 
development of tolerance to acute ethanol, they do not elucidate a mechanism by which 
this might be happening. It has been shown that PUFAs are central to CNS signaling as 
components central to neurotransmitter release. Specifically PUFAs are enriched in 
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synaptic membranes [135] and their loss results in a decrease of cholinergic 
neurotransmission through deficient recycling of vesicular proteins, which can be 
rescued by PUFA supplementation [117, 142]. In order to assess the possible role of 
cholinergic neurotransmission in the development of AFT we used the 
acetylcholinesterase inhibitor aldicarb. Aldicarb inhibits the degradation of acetylcholine 
to acetate and choline. The subsequent buildup of acetylcholine causes a tonic 
paralysis. The time necessary for paralysis is indicative of the amount of acetylcholine 
being released. Specifically, a mutant that release more acetylcholine will paralyze 
sooner while a mutant that releases less acetylcholine will paralyze later. We predicted 
that if AFT is dependent on cholinergic signaling that mutants unable to develop 
tolerance will be resistant to aldicarb, and furthermore, fatty acids that are able to 
rescue AFT will also rescue aldicarb resistance. In agreement with our hypothesis fat-
1(wa9) and fat-4wa14) were both resistant to aldicarb compared to N2 (Figure 8A) and 
supplementation of EPA was able to rescue aldicarb resistance in both mutant 
backgrounds (Figure 8C,D). Not in agreement with our hypothesis, AA was also able to 
rescue aldicarb resistance in fat-4(wa14) and fat-1(wa9) (Figure 8C,D) suggesting that, 
unlike in our AFT assays, AA was able to rescue cholinergic neurotransmission without 
being converted to EPA. These results suggested that while fat-1(wa9) and fat-4(wa14) 
mutants are deficient in cholinergic signaling, its rescue by EPA and AA 
supplementation does not correlate with the rescue of AFT that we observed.  
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6.4 Discussion 
 Based on the knowledge that the lipid microenvironment around ethanol 
responsive proteins can alter their function and response to ethanol we asked if specific 
species of fatty acids may be responsible for this response. This worked aimed to 
determine the role of LC-PUFAs in the response to acute ethanol. We determined that 
LC-PUFAs modulate the initial sensitivity to ethanol and that EPA is the main LC-PUFA 
that modulates the development of AFT. Furthermore, dietary supplementation of EPA 
is able to rescue genotypes that are unable to synthesis the fatty acid and this 
supplementation does not need to occur throughout development.  LC-PUFA 
supplementation has been shown to rescue cholinergic signaling possibly through 
interactions with synaptojanin [142]. Intriguingly, AA and EPA both rescue cholinergic 
signaling in a fat-1 mutant whereas only EPA rescues the development of AFT. This 
suggests that the mechanism for AFT in these supplemented strains is not cholinergic in 
nature.  
 Given that our results suggest a non-cholinergic mechanism for EPA’s rescue of 
AFT, alternative hypotheses are necessary. One hypothesis is that EPA alters lipid raft 
composition and this has functional consequences for interacting proteins that are 
involved in AFT. It has been shown that dietary n-3 fatty acids, such as DHA and EPA, 
alter both the lipid raft structure and the signaling of proteins known to reside in lipid 
rafts [199]. Numerous papers have shown modulation of BK channel activity by lipids 
[40, 41, 43, 45, 179-181]. These results agree with the hypothesis of Bettinger et al. that 
SLO-1, the C. elegans BK channel and known target of ethanol, is trafficked to lipid rafts 
in order to modulate its activity in response to acute ethanol [110]. We may be 
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observing a similar effect with loss and supplementation of EPA. If EPA either interacts 
directly with SLO-1 or aids in altering its localization, then in mutant backgrounds that 
lack EPA we’d expect to observe intoxication without the development of AFT. In 
agreement with this theory, this is what we observed. Further testing involving crosses 
and monitoring of SLO-1 activity will be necessary to test this hypothesis.  
 There has been increasing interest in treating neurological disorders with omega-
3 fatty acids. Maes et al. demonstrated abnormal omega-3 fatty acid metabolism in 
depressed patients and showed that this was not reversed in traditional antidepressant 
therapy in some patients [200]. Peet et al. determined that omega-3 fatty acid 
concentrations are lower in red blood cell membrane, thought to relate directly to the 
neuron membrane concentration, in depressed patients compared with controls [201]. 
Major depressive disorder and alcohol abuse disorders (AUD) have been shown to be 
co-morbid although the low number of patients treated for AUDs decreases the power of 
these studies [2, 202]. Decreases in omega-3 fatty acids also correlate with deficiencies 
in dopaminergic signaling [203], a pathway that has been shown to respond profoundly 
to both acute and chronic ethanol [24, 28, 48, 50, 51, 204]. Furthermore, EPA/DHA 
supplementation for three weeks was found to significantly reduce stress and cortisol 
levels in abstinent alcoholics [205] suggesting a role for omega-3 supplementation in 
AUDs beyond the involvement of ethanol. The data presented in this paper support a 
role for EPA in the ethanol response but does not test the possible role of dopamine. 
Dopamine has been shown to alter state-dependent recognition of an odorant when 
paired with ethanol [74] and is necessary for disinhibition of feeding behavior by ethanol 
[19]. Future work with EPA should assess its ability to modulate dopaminergic signaling 
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especially in response to ethanol. This line of investigation could identify possible 
dopaminergic targets for EPA thus furthering our understanding of the mechanisms that 
underlie AFT. 
 Microarray studies have consistently identified lipid metabolism genes as being 
altered in alcoholics [206, 207]. These include genes involved in elongation and 
desaturation of fatty acids as well as their transport and synthesis of their derivatives. Of 
particular interest was the finding that FADS1 and FADS2 were misregulated in 
alcoholic brain tissue. Polymorphisms in these same genes have been shown to alter 
lipid profiles in humans [133]. Additionally, a study by Corella et al. found a novel 
interaction between MC4R and FTO polymorphism, known to affect obesity, and a 
decrease in drinking behavior [208] although this study did not look at possible 
differences in lipid profiles as a result of the polymorphisms. Taken together these 
studies suggest that lipid profile, metabolism, and ethanol interact and provide strong 
evidence for diet to be considered as a possible environmental factor in alcoholic gene 
interactions. Future studies that assess naïve response, like the work of Schuckit [209], 
should consider determining the lipid profile of the subjects. Additionally, work in mice or 
rats could alter dietary intake of omega-3s and test for a correlation between their levels 
and ethanol responding. It would be particularly interesting if omega-3s modulated 
dopamine and ethanol responding as the magnitude of dopamine release during the 
first exposure to ethanol was shown to be predicative of voluntary drinking in rats [56]. 
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6.5 Figures 
 
 
 
 
 
 
 
Figure 3. fat-3(wa22), fat-4(wa14), and fat-1(wa9) all fail to develop AFT. 
Additionally fat-3(wa22) is sensitive to the intoxicating effects of ethanol at 
ten minutes.  
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Figure 5. Supplementation with AA (A) or EPA (B) resulted in increased development of 
AFT in N2. AA supplementation also increased the initial sensitivity in N2 (A).  
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Figure 6. Basal speeds for all strains treated with vehicle, AA, or EPA. EPA 
rescued all basal speeds. AA rescued fat-4(wa14) and fat-3(wa22) but not fat-
1(wa9) basal speeds.  
55 
 
 
 
 
Figure 7. Nineteen hour treatment of fat-1(wa9) with EPA was sufficient to 
rescue AFT (A) but not basal speeds (B).  
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Figure 8. fat-1(wa9) and fat-4(wa14) are resistant to the paralyzing affects of aldicarb (A). 
EPA and AA supplementation do not alter aldicarb sensitivity in N2 (B). fat-4(wa14) 
aldicarb resistance is rescued by EPA and AA (C). fat-1(wa9) aldicarb resistance is also 
rescued by EPA and AA (D).  
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7 The Role of Palmitoylation in the Level of Response to Ethanol 
Abstract 
An individual’s naïve level of response (LR) to ethanol is predictive of his or her lifetime 
likelihood to abuse alcohol. LR is heavily genetically influenced, suggesting that the 
genes responsible for LR may also be central to the development of abuse disorders. 
Our laboratory uses the model organism C. elegans to investigate the genetic 
influences on responses to acute ethanol exposure. We have focused on two 
components of LR: initial sensitivity, measured as the change in mean velocity over the 
first ten minutes of treatment, and the development of acute functional tolerance (AFT), 
measured as an increase in the mean velocity at thirty minutes versus ten minutes of 
exposure. We have previously found that SLO-1, the large-conductance potassium (BK) 
channel, is a target of ethanol. slo-1 mutant animals are profoundly resistant to ethanol, 
and are defective in AFT. Recently, we used a forward genetic screen for mutations that 
disrupt the ability of worms to develop AFT to identify ctbp-1, a transcriptional repressor 
that affects AFT through its negative regulation of a triacylglyceride lipase, lips-7. lips-7 
mutants have the opposite phenotype; enhanced development of AFT. Preliminary 
analysis of the lipid profile of the lips-7 mutant versus wild type has suggested that lips-
7 mutants may have an increase in palmitic acid. This led us to ask if and how palmitic 
acid may be involved in AFT. Palmitoylation, the reversible addition of a palmitic acid to 
a protein, can alter ion channel activity both directly and indirectly. Mouse mSLO-1 has 
multiple palmitoylation sites that affect localization, internalization, activity, and 
trafficking. This suggests one model for AFT in which the effects of ethanol on targets 
such as SLO-1 are modulated by palmitoylation. We have tested the ethanol responses 
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of animals with loss-of-function of various genes related to the synthesis, degradation, 
or use of palmitic acid, and have identified several of these genes that alter both initial 
sensitivity and AFT. These results strongly support the model that palmitoylation is 
required for AFT. Our goal is to better understand how the palmitoylation machinery 
modifies acute responses to ethanol.  
7.1 Introduction 
 We have chosen to study the genetic influences on LR using the model organism 
Caenorhabditis elegans. C. elegans provides a simple system to understand the genetic 
and molecular effects of ethanol intoxication. We observe intoxication in C. elegans at 
doses that cause intoxication in mammals, and genes that have been identified in 
worms that modify ethanol responses, when they have been tested in rodents, also 
modify ethanol responses [41, 102, 106, 108, 109]. These observations suggest a 
conserved mechanism for intoxication between C. elegans and mammals. This initial 
response to ethanol is comprised of at least two components that are conserved and 
can be assessed experimentally in C. elegans: initial sensitivity and the development of 
acute functional tolerance (AFT). Initial sensitivity corresponds to the magnitude of 
intoxication at its maximum effect, and in C. elegans we observe initial sensitivity as the 
maximum loss of speed at ten minutes of ethanol exposure. AFT is the summation of 
homeostatic mechanisms utilized by the nervous system to adapt to the intoxicating 
effects of a single dose of ethanol, and in humans is observed as the recovery in 
behavioral impairment over the course of a single drinking bout at the same or higher 
blood alcohol concentrations. In C. elegans, AFT is measured as a recovery in 
locomotion between the ten and thirty minute time points of an ethanol exposure assay. 
59 
 
Over this time period the worms’ speed increases, and this increase does not reflect a 
decrease in the tissue concentration; previous work in the laboratory has demonstrated 
that there is an increase in the internal ethanol concentration over the time course of 
this assay, demonstrating that AFT is neither due to altered metabolism nor a change in 
the pharmacokinetics or ethanol [99]. 
 We have developed a model of the development of AFT that involves lipid 
modulation of protein activity via palmitoylation during exposure to ethanol. This model 
is based on several converging lines of data. First, a forward genetic screen for mutants 
that were unable to develop AFT identified a mutation in ctbp-1 [110]. Chen et al. 
showed that CTBP-1 is a negative regulator of lips-7, a gene encoding a triacylglyceride 
(TAG) lipase and that TAG levels in ctbp-1 mutant animals were 16.8% lower than in 
wild type [111]. Our laboratory found that a loss of lips-7 resulted in initial resistance and 
exaggerated development of AFT, indicating that altered lipid levels affect the initial 
response to ethanol in vivo [110]. We have begun to examine the change in lipid profile 
in the lips-7 mutant animals relative to wild-type. A GC/MS lipid analysis of lips-
7(ok3110) mutant animals showed a potential increase in palmitic acid (unpublished 
results, Figure 9), which led us to hypothesize that palmitic acid may be modulating the 
initial response to ethanol in C. elegans via palmitoylation of ethanol-affected proteins. 
In further support of our model, our laboratory has previously identified SLO-1, a large 
conductance potassium channel, as a major target of ethanol. slo-1 null mutant animals 
exhibit resistance at ten minutes and a marked reduction in AFT [39, 110]. In both C. 
elegans and mouse, SLO-1 is inappropriately activated by ethanol and this likely causes 
hyperpolarization of the neuron [39]. Importantly, the lipid microenvironment around 
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SLO-1 modulates ethanol’s effects in vitro [41]. Furthermore, our group has 
demonstrated that a lips-7 mutation suppresses a slo-1(gf) phenotype, indicating that 
the altered lipid levels in the lips-7 mutant background have effects on SLO-1 channel 
activity [110]. This suggests that lipids have a direct role in the channel’s activity and 
that the lipid microenvironment may either provide fatty acid substrate for palmitoylation 
or be the targeted destination of palmitoylated proteins. 
 Palmitoylation is the reversible addition of an activated palmitic acid to a cysteine 
residue of a protein through a thioester bond. This linkage is achieved by the action of a 
palmitoyltransferase and can be reversed by a thioesterase (Figure 10). While not much 
is known about the specificity of palmitoyltransferases for their targets, many ion 
channels have been shown to be palmitoylated. Of particular interest to our lab are 
GABA-A, NMDA, and SLO-1 channels (also known as BK channels), all known targets 
of ethanol, all of which are palmitoylated [176, 178-181, 204]. Palmitoylation has been 
shown to affect trafficking of channels between the endoplasmic reticulum, Golgi, and 
the plasma membrane as well as the localization within the membrane, the activity of 
some channels, as well as modulating the internalization and subsequent recycling or 
degradation (as reviewed by Shipston MJ in [182]). Most proteins that have been shown 
to be palmitoylated contain multiple palmitoylation sites with each modulating an 
individual process. Any of these effects may contribute to a change in the activity of an 
ethanol response protein, and we hypothesize that one or more may account for the 
very fast development of AFT that is observed in C. elegans and in mammals. This has 
led us to develop the following Specific Aims:  
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Aim 1: Determine if the loss of palmitoyltransferases can affect the initial 
response to ethanol.  
Aim 2: Determine if altered lipid metabolism can affect the initial response to 
ethanol.  
Aim 3: Use site directed mutagenesis of cysteine residues on the known ethanol 
target  SLO-1 to determine if it is palmitoylated and if palmitoylation is 
necessary for the development of AFT.  
Aim 4: Identify the targets of palmitoyltransferases that cause altered initial 
sensitivity and AFT. 
 
 
7.2 Methods 
 
7.2.1 Worm husbandry 
C. elegans strains were maintained on nematode growth medium (NGM) plates with E. 
coli as a food source [67]. Strains used in this study were N2 (var. Bristol), VC168 ppt-
1(gk134), VC771 dhhc-14(gk330).  
 
7.2.2 RNAi 
RNAi induction was performed as previously described [210]. Cultures of RNAi vector 
containing bacteria from the RNAi feeding library generated by J. Ahringer at the 
University of Cambridge (Geneservice, Cambridge, UK) were grown in LB with 50 µg/ml 
62 
 
ampicillin for 12 to 18 hours at 37°C while shaking. RNAi containing bacteria were 
seeded on to NGM plates supplemented with 1 mM IPTG and 25 µg/ml ampicillin (RNAi 
plates) and incubated at 20°C for 24 hours. Ten L4 stage N2 worms were placed on 
each seeded plate and allowed to develop to adulthood for 24 hours. Gravid adults were 
moved to new RNAi plates and allowed to lay eggs for one hour. Eggs were incubated 
at 20°C and allowed to develop to first day adults. These first day adults were used for 
behavioral assays. 
 
7.2.3 Locomotion tracking 
Speed was analyzed as described previously [101] with minor changes: Assay plates 
were dried for one hour at 37°C with the lids removed. Copper rings were heated and 
melted into the surface of the plates. Ice-cold 100% ethanol was added to a final 
concentration in agar of 0 mM or 400 mM. Plates were immediately sealed with Parafilm 
and the ethanol was left to soak into the plate for two hours at room temperature. Age-
matched first day adults were acclimated by moving them to unseeded plates with 
copper rings for thirty minutes. Ten worms of each strain were then moved into the 
corresponding copper ring on the assay plates. Movies of their movements were 
recorded at ten and thirty minutes of exposure. Movies were made on an Leica MZ6 
stereo microscope with a 0.5x objective and 0.8x magnification using a Retiga 4000R 
camera (QImaging) and ImagePro Plus (6.2) (MediaCybernetics) software. Two-minute 
recordings were made at one frame per second and the speed of each worm was 
tracked using ImagePro Plus software. The average speed for each group was 
calculated and treated as a single trial. All strains were tested a minimum of three times.  
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7.2.4 Assessment of ethanol response 
A relative speed for each time point is calculated by dividing the treated speed by the 
untreated speed within a genotype. We assess initial sensitivity by comparing the ten 
minute relative speeds between strains. A statistical difference in the speeds reflects a 
significant change in the initial sensitivity. We next compare the ten and thirty minute 
relative speeds within a strain to determine if AFT has developed. A statistically 
significant increase in the relative speed at thirty minutes is AFT. Lastly, we compare 
the degree of AFT between strains. AFT is quantified as percent recovery of speed and 
is calculated by subtracting the ten minute relative speed from the thirty minute relative 
speed. A statistically significant difference between strains’ percent recovery reflects a 
significant difference in AFT.  
 
7.2.5 Statistics 
Animals that were compared were treated one the same plate with speeds determined 
at the same time under identical conditions. Data were converted to relative speeds to 
account for basal speed differences between strains and for ease of viewing the results 
between experiments. Statistics were performed using Prism 5.0 (GraphPad). All 
comparisons were made to the control under the same condition and were calculated 
using paired two-tailed t-tests.  
 
7.2.6 Lipid isolation  
Lipids were extracted from whole worms as previously described [130] with slight 
modifications. Several thousand worms were washed from sixty 10 cm plates with water 
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and placed into 1.5 mL Eppendorf tubes. Worms were pelleted by centrifugation at 
1,000 x g for 1 minute. As much water as possible was removed and 1 mL of 2.5% 
H2SO4 in methanol was added to the tube. The contents were transferred to glass 
scintillation vials and sonicated for 5 minutes in a Branson 2510 water bath sonicator at 
room temperature. The homogenate was transferred to a 1.5mL Eppendorf tube and 
incubated at 80°C for one hour. The samples were then transferred to a glass vial and 
0.2 mL of hexane and 1.5 mL of water were added. Fatty acid methyl esters were 
extracted into the hexane layer by vigorous shaking and centrifugation at 1,000 x g for 
one minute. The hexane layer was removed and given to Justin Poklis for analysis at 
the Department of Pharmacology and Toxicology GC/MS Core.   
 
7.3 Results 
7.3.1 Aim 1: Determine if RNAi knockdown and loss-of-function of suspected 
palmitoyltransferases results in altered ethanol response phenotypes.  
To ascertain the role of palmitoylation in initial sensitivity and AFT, we took the 
approach of assessing the ethanol response of mutant animals lacking the activity of an 
individual palmitoyltransferase. We predicted that loss of certain palmitoyltransferases 
would alter the initial sensitivity and/or the development of AFT.  C. elegans has at least 
fifteen suspected palmitoyltransferases, most of which are named for the conserved 
sequence of aspartate, histidine, histidine, and cysteine (DHHC).  
Available loss-of-function alleles for each palmitoyltransferase were ordered from 
the Caenorhabditis Genetic Center. If mutant alleles were not available, we generated 
RNAi knockdown of target genes by feeding the worms E. coli expressing double-
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stranded RNA against the gene of interest. All RNAi expressing bacterial strains were 
sequenced to ensure the proper gene was being targeted. Additionally, sequences were 
subjected to a BLAST search to find any possible off-target genes that may be knocked 
down. To date, we have tested eight of the 15 candidate palmitoyltransferases, and 
three altered the ethanol response phenotype.  
RNAi knockdown of the suspected palmitoyltransferase dhhc-6 resulted in a 
minor decrease in initial sensitivity and a significant reduction in AFT compared to 
worms fed an empty vector plasmid (Figure 11). This combination of initial resistance 
with a subsequent reduction in AFT phenocopied slo-1 mutant worms. One possible 
interpretation of this result is that palmitoylation by DHHC-6 is necessary for the 
membrane expression of an ethanol target, perhaps SLO-1, either through trafficking or 
inhibition of internalization, and its loss both causes resistance and removes the chance 
for modulation of the target leading to a reduction in AFT.  
A loss of function of dhhc-14 resulted in an altered ethanol response phenotype 
from that of dhhc-6. dhhc-14(gk330) mutant animals trended toward increased 
sensitivity to ethanol compared to wild-type worms at ten minutes and, like dhhc-6 
knockdowns, these animals developed significantly less AFT (Figure 12), indicating that 
DHHC-14 activity is essential for the complete development of AFT. This result was of 
particular interest as it could be explained by a model where palmitoylation by DHHC-14 
is not necessary for membrane expression of the ethanol target but is necessary for 
adaptation to ethanol activation via internalization or movement into a protective 
membrane microdomain. 
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RNAi knockdown of the palmitoyltransferase hhat-2 resulted in a significant 
decrease in initial sensitivity with near wild-type AFT (Figure 13). While the initial 
resistance could be explained by a loss of an ethanol-target at the plasma membrane, 
the unaffected AFT suggests that hhat-2 is not involved in the development of tolerance. 
Furthermore, this result could be interpreted as palmitoylation resulting in sensitivity to 
ethanol and suggests that the balance between palmitoylation and depalmitoylation may 
modulate the homeostatic mechanisms triggered by ethanol.  
To further investigate a role for palmitoylation state in ethanol responses, we 
tested a  ppt-1 loss of function allele. ppt-1 encodes a thioesterase that is predicted to 
function in the removal of palmitic acid from palmitoylated proteins. In this mutant we 
would expect the dynamics of palmitoylation to be affected. ppt-1(gk134) mutant 
animals displayed wild-type initial sensitivity to ethanol with a complete loss of AFT 
(Figure 14). These results would agree with a model where the mechanism of AFT is 
the degradation of palmitoylated proteins. Furthermore, this is the fourth distinct 
phenotype that we have identified from our examination of four palmitoylation-related 
enzymes which suggests that each enzyme may act on distinct palmitoylation sites 
either within a single protein or, more likely, between many proteins. While the current 
results do not yet allow for the development of a cohesive model, they do show that 
palmitoylation is a complicated mechanism that is, in part, responsible for the level of 
response to ethanol in C. elegans.  
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7.3.2 Aim 2: Determine if altered levels of fatty acids modulate ethanol response in    
C. elegans. 
We next tested the importance of palmitoylation in the dynamic response to 
ethanol by altering the metabolism of palmitic acid. Much work has been done 
elucidating the enzymes responsible for fatty acid metabolism in worms [174]. RNAi 
knockdown of elo-2, the elongase responsible for conversion of palmitic acid to stearic 
acid, has been demonstrated to result in a marked increase in palmitic acid with 
subsequent decreases in C18:1n9 and C20:2n6 fatty acids [211]. We found that elo-2 
knockdown animals had wild-type initial sensitivity, but, like ppt-1(gk134) animals, 
completely lost their ability to develop AFT (Figure 15). This result showed that the lipid 
profile of a worm can dramatically affect its development of tolerance to ethanol. 
Whether the loss of AFT in elo-2 knockdown animals is due to the increase in palmitic 
acid, the reduction of other fatty acids, or some combination of the two is currently 
unclear. Many mechanisms involving lipid interactions may exist that are necessary for 
the development of AFT which do not involve palmitoylation. With this in mind, models 
investigating the role of specific lipids in AFT should be kept separate from those 
involving palmitoyltransferases until the data suggests otherwise.  
 
7.4 Discussion 
Our data suggest that there is an important role for palmitoylation in the acute 
response to ethanol. While we are not aware of any direct studies of the role of 
palmitoylation in the response to ethanol before our work, there are several 
observations that support a role for palmitoylation in the ethanol response in mammals. 
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Ethanol administration has been shown to alter hepatic protein palmitoylation and 
trafficking in mice after one week of chronic administration [212]. Chronic administration 
of opiates has also been shown to alter the palmitoylation states of Gs alpha and PSD-
95, which correlated with in increased adenylyl cyclase activity and increased 
conditioned place preference to ethanol, respectively [212, 213]. These researchers 
suggest that the drug they administer misregulates the palmitoylation of their proteins of 
interest. We hypothesize that changes in palmitoylation states may also be the 
homeostatic response to a drug and that targeting palmitoylation may alter the 
molecular responses to a drug and perhaps interrupt cellular changes necessary for 
behaviorally important responses to ethanol in mammals. The human homologues of 
dhhc-6, dhhc-14, ppt-1, and elo-2 (ZDHHC6, ZDHHC17, PPT1 and ELOVL4, 
respectively) are differentially expressed in the brains of alcoholics [207]. We are 
particularly intrigued by the fact that these are the human homologs of the 
palmitoylation genes for which we observed ethanol response phenotypes in our studies 
in worms. In addition, the functions of several known ethanol targets are modified by 
palmitoylation. We have shown, through genetic manipulations of palmitoylation-related 
genes, that palmitoylation plays an important role in the initial response to ethanol and 
the subsequent development of acute functional tolerance. Given that an individual’s 
initial response to alcohol can be predictive of their likelihood to abuse alcohol, these 
palmitoylation genes represent attractive targets of research for understanding both the 
molecular responses to ethanol and addiction.  
 Our future studies will aim to identify the molecular targets of the 
palmitoyltransferases and to understand their roles in the response to ethanol. We have 
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identified the BK channel, SLO-1, as a likely candidate for palmitoylation for several 
reasons. First, there is experimental evidence that the mammalian SLO-1 (mSLO-1) is 
palmitoylated [179, 180]. Second, mSLO-1 is extremely homologous to C. elegans  
SLO-1. Third, we and others have observed that alterations in lipid profile can affect 
SLO-1 activity both in vivo [110] and in vitro [41]. Finally, we have used the CSS-Palm 
3.0 software to predict palmitoylation sites in SLO-1. We have identified three cysteine 
residues on the SLO-1a isoform that are likely sites of palmitoylation. We will use site-
directed mutagenesis to change each cysteine residue to an alanine, thereby preventing 
any palmitoylation at that site, and assess the ethanol response for each mutation. In 
this way, we may identify specific cysteine residues that are important in the initial 
response to ethanol.  
 We anticipate that additional studies will involve the identification of proteins that 
are palmitoylated during the development of AFT using cysteine accessibility assays 
and acyl-biotin exchange [214]. By manipulating the chemistry of the thioesterase bond, 
these techniques would allow us to biotin label proteins that have been palmitoylated, 
purify them and identify them by mass spectrometry. This global approach may be 
useful in confirming known channels that are palmitoylated as well as identifying novel 
targets of palmitoylation specifically during the development of AFT. A subtraction 
approach could also be used in palmitoyltransferase knockout animals to identify the 
targets of specific palmitoyltransferases. This technique, combined with the ethanol 
response assays could yield strong evidence for the role of specific proteins in AFT. 
Further behavioral experiments with animals in which these proteins are knocked out 
could confirm their role in ethanol response.  
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 These studies highlight palmitoylation as one homeostatic mechanism that is 
likely to be required for the development of AFT. Understanding the interactions 
between ethanol response and palmitoylation will help us identify potential targets for 
pharmacological intervention for alcoholism in humans. 
 
7.5 Figures 
 
 
Figure 9. Loss of lips-7 results in an altered lipid profile. a) GC/MS analysis of wild-
type worms. Note the ratio between 16:0 and 16:1 fatty acids (palmitic and palmitoleic 
acids, respectively). b) GC/MS analysis of lips-7(ok3110) shows a possible increase in 
palmitic acid (16:0, arrow) when compared to palmitoleic acid (16:1) and this ratio 
appears to be different between the genotypes. This result suggests that palmitic acid 
may be increased in the lips-7(ok3110) background and may be partly responsible for 
the decrease in initial sensitivity and increased development of AFT. Data collected by 
Justin Poklis of the GC/MS Core (VCU). 
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Figure 10. Protein palmitoylation is controlled palmitoyltransferases and 
thioesterases. Palmitoylation is the reversible addition of an activated palmitic acid to 
the cysteine residue of a protein by a palmitoyltransferase. This lipid modification can be 
removed by a thioesterase.  
 
 
 
Figure 11. Reduction in DHHC-6 alters initial sensitivity and AFT. RNAi knockdown 
of the suspected palmitoyltransferase encoded by dhhc-6 resulted in a phenotype that 
displayed initial resistance to the intoxicating effects of ethanol and a significant 
reduction in the development of AFT compared to wild-type worms fed empty plasmid 
vectors (n = 3). Error bars are s.e.m. For indicated comparisons: n.s., not significant; *, 
p < 0.05; **, p<0.01.  
n.s
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Figure 12. Loss of dhhc-14 increases initial sensitivity and decreases AFT. dhhc-
14(gk330) mutant animals trended towards increased initial sensitivity to the intoxicating 
effects of ethanol and a significant reduction in the development of AFT compared to 
wild-type worms (n = 3). Error bars are s.e.m. For indicated comparisons: n.s., not 
significant; *, p < 0.05. 
 
 
Figure 13. Reduction in HHAT-2 decreases initial sensitivity and does not affect 
AFT. RNAi knockdown of the suspected palmitoyltransferase encoded by hhat-2 
resulted in a phenotype that displayed initial resistance to the intoxicating effects of 
ethanol and wild-type development of AFT compared to wild-type worms fed empty 
plasmid vectors (n = 3). Error bars are s.e.m. For indicated comparisons: n.s., not 
significant; *, p < 0.05; **, p<0.01; for comparison to wild-type: †, p < 0.05.  
n.s
n.s
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Figure 14. Loss of ppt-1 does not affect initial sensitivity and abolishes AFT. ppt-
1(gk134) mutant animals displayed wild-type initial sensitivity to the intoxicating effects 
of ethanol and a complete loss of AFT compared to wild-type worms (n = 3). Error bars 
are s.e.m. For indicated comparisons: n.s., not significant; *, p < 0.05, **, p < 0.01. 
 
 
Figure 15. Reduction in ELO-2 does not affect initial sensitivity and abolishes 
AFT. RNAi knockdown of the elongase responsible for the conversion of palmitic acid to 
stearic acid resulted in wild-type initial sensitivity to the intoxicating effects of ethanol 
and complete loss of AFT compared to wild-type worms fed empty plasmid vectors (n = 
3). Error bars are s.e.m. For indicated comparisons: n.s., not significant; *, p < 0.05. 
 
 
n.s
n.s
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8 Summary of Results 
The work displayed in the previous two chapters highlights the involvements of palmitic 
acid and eicosapentaenoic acid in the level of response to acute ethanol in C. elegans.  
EPA is necessary and sufficient to rescue AFT in mutant backgrounds that lack 
some or all LC-PUFAs. The mechanism by which EPA alters ethanol responding is 
unknown and EPA rescue does not correlate with cholinergic signaling. This leaves 
many possible roles for EPA in the ethanol response that must be tested. Briefly, EPA 
may be acting through (1) alterations in membrane fluidity or lipid microdomains, (2) 
lipid signaling either directly as a free fatty acid or as a precursor to a signaling 
molecule, or (3) direct protein interactions either on a target of ethanol or a protein 
necessary in the response to ethanol, or (4) gene regulation by EPA prior to ethanol 
exposure may alter the expression of ethanol-responsive proteins.  
The loss of specific palmitoyltransferases, the enzymes responsible for attaching 
a palmitate to a protein, alters the acute response to ethanol in C. elegans. 
Palmitoylation of known protein targets has been demonstrated [176-182]. We have 
developed a hypothesis that the membrane localization of SLO-1 alters its activation by 
ethanol and that movement of the channel in and out of lipid microdomains allows for 
the development of AFT. It is also possible that additional targets of ethanol were being 
affected in our assays as at least three distinct phenotypes emerged. Numerous 
possible changes could occur in response to protein palmitoylation both directly to the 
protein (see Figure 2) and indirectly to any complexes the protein interacts with. 
Palmitoylation of a protein may move it into a protective lipid domain, move it into 
contact with its partners in a signaling complex or cascade, sequester the protein away 
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from its signaling cascade, or lead to downregulation of the protein through 
internalization.  
All of the possible mechanisms for the involvement of these fatty acids warrant 
further investigation. To this end the following section will propose a few experiments or 
lines of investigation in hopes of elucidating a mechanism of action.  
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9 Future Directions 
9.1 Lipid profiles in alcoholics 
The level of omega-3 fatty acids has been shown to be altered in some patients 
suffering from mood disorders [200, 201, 203, 215-217]. Omega-3 fatty acid levels have 
also been shown to correlate with dopamine release in rodent models suggesting a 
possible mechanism for omega-3 involvement in depression [203]. Co-morbidity of 
mood disorders, alcohol use, and alcohol abuse have also been found [2, 202] . Given 
that numerous lipid metabolism genes have been found to be either misregulated in 
alcoholics [206, 207] or alter ethanol responses (e.g., KLF-3 (unpublished result), fat-1, 
fat-4, fat-3, elo-2, elo-1, fat-5, fat-6, ctbp-1, and lips-7) I recommend mammalian 
studies, especially in humans, monitor red blood cell lipid profiles when testing the 
effects of acute and chronic ethanol [56, 126, 200, 201]. There are two important 
questions to be asked in these studies: (1) Is lipid profile predicative of level of response 
to ethanol? And (2) Are lipid profiles altered by chronic ethanol exposure? It is very 
possible that these two questions are intimately related. If the initial response to ethanol 
is affected by lipids and the response then alters the lipid profile one could imagine a 
feedback loop. While I believe the entire lipid profile should be measured, I expect that 
changes in omega-3 levels (EPA and DHA) will most likely be observed. It is important 
to note that while C. elegans does not have DHA, I expect the roles of EPA in the 
nematode may mimic the roles of DHA in mammals. This comes from the observation 
that EPA is enriched in neuronal membranes in C. elegans while DHA is enriched in 
mammalian neuronal membranes [117, 142, 199, 218, 219].  Additionally, changes in 
palmitic acid may also be expected given our results with palmitoyltransferases.  
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Changes in the mammalian system may help identify new genes or signaling molecules 
of interest. For example, if a single fatty acid change is correlated to ethanol response 
then the metabolites of that fatty acid should be investigated as well as any known 
receptors or interacting proteins.  
9.2 Altering lipid levels may change the response to ethanol 
 Whether or not lipid profiles correlate with ethanol response or are altered in 
response to ethanol, a still larger question remains: Can dietary fatty acids alter the 
response to ethanol? We know that the initial response to ethanol is predicative of 
abuse liability [94] and that the level of response is composed of at least the initial 
sensitivity and the development of AFT [191]. The level of dopamine release during the 
first exposure to ethanol has been shown to be predictive of voluntary drinking in 
multiple rat strains [56] and omega-3 fatty acids have been shown to alter dopamine 
release in rodent models [203, 217, 220]. Taken together, a possibility emerges that 
altering dopamine release through dietary omega-3 fatty acids will alter the response to 
ethanol. Testing with the no, low, and high omega-3 diets could be performed in the 
loss-of-righting reflex assay. This would test if diet can alter the initial response to 
ethanol. Additionally, switching the diets of stably responding mice should be tested to 
see if it alters ethanol responses. Being able to alter stable responding by switching diet 
would be a strong argument for omega-3 treatment of AUDs. Further testing of this 
possibility could include monitoring of dopamine levels, preferably in the NAC, by 
microdialysis. Both the initial and subsequent dopamine releases should be monitored 
with each ethanol administration. This may not be possible in a voluntary drinking 
paradigm so ethanol-induced dopamine release should be monitored at various time 
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points to assess change over time. Changes in ethanol induced dopamine release 
caused by EPA supplementation could suggest changes in the rewarding properties of 
alcohol although this would not be a measure of reward. These experiments would give 
valuable insight into how dietary fatty acids could alter responding and potentially abuse 
liability. Omega-3 diets have also been shown to reduce stress in abstinent alcoholics 
[205] and fatty acid metabolism has been suggested as a target for treating cocaine 
addiction [143, 144]. It is possible that a diet rich in omega-3 fatty acids should be 
tested as a treatment for alcohol abuse disorders.  
9.3 Site-directed mutagenesis of SLO-1 palmitoylation sites and monitoring of 
localization 
We have identified the BK channel, SLO-1, as a likely candidate for 
palmitoylation for several reasons. First, there is experimental evidence that the 
mammalian SLO-1 (mSLO-1) is palmitoylated [179, 180]. Second, mSLO-1 is extremely 
homologous to C. elegans SLO-1. Third, we and others have observed that alterations 
in lipid profile can affect SLO-1 activity both in vivo [110] and in vitro [41]. Finally, we 
have used the CSS-Palm 3.0 software to predict palmitoylation sites in SLO-1. We have 
identified three cysteine residues, Cys73, Cys74, and Cys659 on the SLO-1a isoform 
that are likely sites of palmitoylation. We could use site-directed mutagenesis to change 
each cysteine residue to an alanine, thereby preventing any palmitoylation at that site, 
and assess first the rescue of the slo-1 null phenotype followed by the ethanol response 
for each rescuing mutant. In this way, we may identify specific cysteine residues that 
are important in the initial response to ethanol. It will be important to test for rescue of 
slo-1 phenotypes with each mutated construct. One of the palmitoylation sites on SLO-1 
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may be important for its proper trafficking to the membrane. If this is the case, we would 
predict that a mutation here would phenocopy a SLO-1 null. Because assessing the 
phenotype may be difficult (e.g., the palmitoylation site involved in ethanol responding 
also causes the phenotypes observed in SLO-1 null, meaning the channel is 
appropriately trafficked but the transformed line phenocopies a null allele) I would 
suggest the addition of a tag to the injected SLO-1. We know we are able to separate 
lipid raft domains and can use UNC-1::GFP as a marker of this (Figure 16). If we’re also 
able to detect SLO-1 in a Western blot, we’d be more confident in determining if the 
mutated SLO-1 was properly trafficked to the membrane. Additionally, this construct 
would allow us to monitor the localization of SLO-1 over time and exposure to ethanol. 
We’ve hypothesized that SLO-1’s movement in the membrane is necessary for the 
development of AFT [110] and that this may be modulated by palmitoylation. These 
experiments may intersect if this hypothesis is correct. If SLO-1 does alter its 
localization in response to ethanol and it’s mediated by palmitoylation, then one of the 
mutated sites may create a construct that rescues the basal SLO-1 phenotypes but 
does not rescue the development of AFT. This would be a very exciting result! 
 The previously tested SLO-1::GFP construct was not reliably detected by 
antibodies we tested so I recommend a FLAG or HA tagged version be used with an 
antibody known to work with the tag.  
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9.4 Identification of palmitoylated proteins in C. elegans 
 Further studies may identify additional ethanol responsive proteins that are 
targets of palmitoylation. I propose the use of acyl-biotin exchange [214] to identify 
proteins that are palmitoylated in response to ethanol and proteins that are no longer 
palmitoylated in a palmitoyltransferase mutant. By manipulating the chemistry of the 
thioesterase bond, this technique would allow us to biotin label proteins that have been 
palmitoylated, purify them and identify them by mass spectrometry. This global 
approach may be useful in confirming known channels that are palmitoylated as well as 
identifying novel targets of palmitoylation specifically during the development of AFT. If 
a large portion of proteins are palmitoylated, then a subtraction approach could also be 
used in palmitoyltransferase knockout animals to identify the targets of specific 
palmitoyltransferases. Results from these experiments would not only identify the 
Figure 16. Detergent resistant membrane (lipid rafts) 
can be isolated from C. elegans. UNC-1 is a protein 
almost exclusively associated with lipid rafts and is thus 
used as a marker lipid rafts.  
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protein involved and the residue that causes the phenotype, but also give the 
mechanism by which it is occurring. This would allow for very focused experiments in 
other model organisms and possibly narrow down polymorphism to look for in GWAS 
studies (i.e. mutations that change a palmitoyltransferase accessible cysteine residue). 
The techniques necessary for these experiments may take time to develop and learn 
but could yield multiple proteins involved in AFT and hopefully multiple publications 
given the highly specific results.  
 
9.5 klf-3 supplementation with fatty acids 
 Mutation of klf-3 decreases palmitic acid levels, increases fat-1 expression (as 
well as changing the expression of many other lipid-related genes) [112] and disrupts 
the development of AFT. Supplementation with EPA or palmitic acid may rescue this 
phenotype. While on its own this would not elucidate the mechanism by which KLF-3 
affects AFT, it would tie into the work presented here and would be another piece of the 
emerging story of fatty acid involvement in the level of response to acute ethanol. 
Likewise, no rescue suggests a mechanism that may be separate from those observed 
in this thesis work which would allow for other lines of investigation.  
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9.6 Ethanol reponses at lower doses 
 We often test various exogenous doses of ethanol when assessing new strains 
of worms. However, we typically only publish the results of 400 and 500 mM exposures. 
This is mainly due to the observation that AFT only develops when the worms become 
sufficiently intoxicated. A 200 mM dose of ethanol results in a significant decrease in 
locomotion at ten minutes with no change in speed at the 30 minute time point. Mutant 
strains, however, can respond differently than N2 at this dose (Figure 17). These three 
mutants (fat-1, fat-4, and fat-3) all fail to develop AFT at 400mM doses of ethanol but 
have different phenotypes from each other at 200 mM. There may be a fundamental 
difference in the pathways affected at 200 and 400 mM ethanol that are also affected 
differently between the fat mutants. A complete curve of the speeds over time at 200 
mM ethanol may offer better insights into what exactly is occurring. While I do not have 
Figure 17. N2, fat-1, fat-4, and fat-3 on 200 mM exogenous 
ethanol. Note the significant reduction in speed from 10 to 30 
minutes observed in fat-4(wa14) and the non-significant but 
obvious decrease in fat-3(wa22). 
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a concrete suggestion for how these phenotypes should be discussed, I think they still 
warrant further investigation and may expose different ethanol response pathways that 
were masked by a 400 mM dose. If these responses are separable, the 200 mM 
response may be confounding some of the 400 mM results.   
 
9.7 Testing of other fat phenotypes 
 Mutations in nearly all the genes involved in fatty acid synthesis were tested for 
their effects on AFT. Mutations in genes that have little or no effect of EPA levels (Table 
Figure 18. Other mutations in the lipid metabolism 
pathway alter LR.  
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1) can still alter AFT. Intriguingly, increases in AFT were observed for strains carrying 
fat-5(tm420). Investigation of the pathway should assess supplementation with any 
altered fatty acids, possible metabolites, as well as a search for genes that may be 
regulated by fat-5. A cursory search on WormBase.org shows many genes interact with 
fat-5 but a few stand out: three nuclear hormone receptors (nhr-35, nhr-49, and nhr-80) 
and two transcription factors (daf-16 and sbp-1). Misregulated genes in the fat-5 
background could be identified by microarray analysis and would yield candidates for 
further testing. A proper lipid profile for fat-5(tm420) should also be completed as one 
does not exist in the literature. Care should be taken in these experiments as loss of 
any of the fat-5, fat-6, or fat-7 desaturases causes upregulation and compensation by 
the remaining two. For this reason different phenotypes can be observed between 
genetic nulls and RNAi knockdown strains [128]. Additionally, if the loss of other fatty 
acids needs to be tested during the course of these experiments Table 2 should offer 
insights into how to target individual fatty acids.  
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Strain LA ALA GLA DGLA O3AA AA EPA IS AFT
fat-1(wa9) NC NC NC ↑ X ↑ X NC X
fat-4(wa14) NC NC NC ↑ ↑ X X NC X
fat-1(wa9); fat-4(wa14) NC NC NC ↑ X X X NC X
fat-3(wa22) ↑ ↑ X X X X X ↑ X
fat-5(tm420); fat-7(wa36) ↑ N.D. N.D. NC NC NC NC N.D. N.D.
fat-5(tm420); fat-6(tm331) NC N.D. N.D. NC NC NC NC NC ↑
fat-6(tm331); fat-7(wa36) X N.D. N.D. X X X X NC X
fat-2(wa17) NC X X ↓ X X ↓ N.D. N.D.
fat-5(tm420) N.D. N.D. N.D. N.D. N.D. N.D. N.D. ↑ ↑
elo-1(wa7) NC NC ↑ ↓ ↓ X ↓ NC ↓
elo-2 (RNAi) N.D. N.D. N.D. N.D. N.D. N.D. N.D. NC X
Table 1. A summary of the approximate change in fatty acid profile  and the resulting 
LR phenotypes. NC = no change, N.D. = not done, X = not detected, ↑ = increase, ↓ 
= decrease. Data compiled from various works by Jennifer Watts.  
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9.8 Lipid signaling molecules derived from EPA 
EPA may be acting as a precursor to signaling molecules that are necessary for 
the development of AFT. Future studies should target the enzymes responsible for the 
metabolism/conversion of EPA. A method similar to the one used by Kulas et al with 
pools of RNAi may be the quickest way to test the 75 P450 genes [187]. Identification of 
a necessary P450 gene could then lead to identification of the EPA-derived signaling 
molecule by GC/MS. If they are stable, the identified molecules could then be 
supplemented into a mutant background deficient in EPA to test the sufficiency of the 
metabolite in the development of AFT. Likewise, upregulation of lipid signaling 
molecules is possible through treatment with fibrates. Results from RNAi knockdown of 
CYP-33E2 and fenofibrate treatment were inconclusive (data not shown) and warrant 
additional trials.  
 
9.9 EPA gene regulation 
While transcription is not necessary for the development of AFT, supplementation with 
EPA may be rescuing AFT by regulating genes that are necessary for its development. 
An 8 hour treatment with EPA was not sufficient to rescue AFT (data not shown) while a 
19 hour treatment was. This could be due to the 19 hour exposure occurring during the 
L4 to adult molt or due to insufficient time for EPA-regulated genes to be adequately 
transcribed and translated. Microarray analysis comparing gene regulation of fat-1(wa9) 
with and without 19 hour EPA supplementation should yield candidate genes. If null 
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alleles of the EPA regulated genes phenocopy fat-1(wa9) then EPA may be rescuing 
AFT through the expression of that gene. Supplementation of EPA of a strain carrying 
the null allele would test this possibility. Likewise a double mutant of the EPA-regulated 
gene with fat-1(wa9) should yield a mutant that cannot be rescued by EPA 
supplementation. This would refine the role EPA is having in rescuing AFT. 
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11 Appendix I - Protocols 
Title: Aldicarb Plates and Assays 
 
Purpose:  
 
This protocol describes how to pour NGM plates that are supplemented with 
aldicarb. Aldicarb is an acetylcholinesterase inhibitor that causes tonic paralysis 
in C. elegans. The time it takes for the worms to paralyze is directly proportional 
to the amount of acetylcholine they release. Strains that release more 
neurotransmitter will paralyze sooner than those that release less.  
 
 
Resources: 
 
Mahoney, T.R., S. Luo, and M.L. Nonet, Analysis of synaptic transmission in 
Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat Protoc, 2006. 
1(4): p. 1772-7. 
 
 
Safety: 
  
Wear gloves and eye protection when working with aldicarb. Work under the 
hood whenever possible. If possible do not pour aldicarb plates in the plate 
pouring room. Either move the pump or pour the plates using a graduated 
pipette. Inhaled aldicarb can cause paralysis.   
 
 
Pouring Aldicarb Plates: 
 
1. Determine the volume of agar required based on the number of aldicarb 
plates required for the assay. Smaller plates are better for this assay.  
 
_________ x ____________ = __________ + 10 mL = _______ 
Number of 
plates 
 Volume per plate 
(typically 5 mL) 
 Exact volume 
required 
 Extra 
volume 
 Volume of 
agar to 
make 
 
 
2. Label an autoclavable bottle that can hold a volume equal to approximately 
twice the volume of agar being made.  
 
100 
 
3. Calculate the mass of aldicarb that will be required. For strains that are 
expected to be resistant use 1 mM aldicarb. For sensitive strains use 0.5 mM 
aldicarb.  
 
_________ x _____ x ________ ÷ 1,000 = ________ 
Concentration 
(mM) 
 
 MW of 
aldicarb 
(g/mol) 
 Volume of 
Agar (L) 
   Mass of 
aldicarb 
(mg) 
 
4. Calculate the amount of water necessary to dissolve the aldicarb to 50 mM: 
 
______ ÷ _____ ÷ _____ x 1,000 = ________ 
Mass of 
aldicarb 
(mg) 
 
 MW 
(g/mol) 
 Concentration 
(mM) 
   Volume of 
dH2O (mL) 
         
5. Dissolve the mass of aldicarb, calculated in Step 3, in the volume of sterile 
dH2O, calculated in Step 4. Leave shaking while autoclaving the agar. If the 
aldicarb is not fully dissolved when the agar is ready, put the tube at 37C for 
15 - 30 minutes.  
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6. Calculate the mass each component required for the agar: 
 
Reagent 
Amount 
per Liter 
 
Volume of 
Agar (L) 
 
Amount Required 
 
NaCl 3 g 
x 
________ 
= 
___________       g 
 
Bacto Agar 16 g 
x 
________ 
= 
___________       g 
 
Bacto Peptone 2.5 g 
x 
________ 
= 
___________       g 
 
1M K3PO4 25 mL 
x 
________ 
= 
___________    mL 
 
1M MgSO4 1 mL 
x 
________ 
= 
___________    mL 
 
1M CaCl2 1 mL 
x 
________ 
= 
___________    mL 
 
5 mg/mL Cholesterol 1 mL 
x 
________ 
= 
___________    mL 
 
 
7. Add the NaCl, Bacto Agar, and Bacto Peptone to the autoclavable container 
and QS to the volume required minus the volume of water needed to dissolve 
the aldicarb in Step 4. Swirl the container.  
 
8. Either loosely screw the cap on the bottle or cover the top with tin foil and 
then add a piece of autoclave tape.  
 
9. Turn on the water bath in the plate pouring room and set it to 60C.  
 
10. Autoclave for the recommended time based on the autoclave specifications.  
 
11. Place the agar in the 60C water bath for 0.5 – 1 hour.  
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12. Add the K3PO4, MgSO4, CaCl2, cholesterol, and aldicarb solution. This can be 
done in or out of the water bath.  
 
13. Swirl the containers.  
 
14. To the control agar add a volume of dH2O equal to the volume used to 
dissolve the aldicarb in Step 4.  
 
15. Ensure the aldicarb is dissolved in the dH2O. If not, warm the solution to 37C 
and vortex. Repeat this until the aldicarb is in solution. Then add the aldicarb 
solution to the aldicarb agar. 
 
16. Swirl both containers.  
 
17. Leave the aldicarb agar in the 60C water bath while pouring the control agar. 
This will allow you to use the same tubing to pour both containers. 
Alternatively, graduated pipettes can be used to dispense smaller batches.  
 
18. Dispense the aldicarb agar using the same settings. If the same tubing is 
being used, consider discarding the first plate poured as it may have less 
aldicarb from residual control plate agar.  
 
19. Label the plates (color coding works well as long as you have a legend with 
the plates).  
 
20. Store plates in the dark at room temperature overnight to solidify.  
 
21. The next day, move plates to a light protected container (e.g., a box wrapped 
in tin foil) and store at either 4 or 20C.  
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Expiration: 
 
Plates have been used for over a month, however the potency of the aldicarb 
decreases over time. All assays being compared should be performed on the 
same day. 
 
Aldicarb Assay: 
 
The timing for the assay will depend on the aldicarb concentration and the 
strains being used. Typically paralysis is assessed every 15 to 30 minutes 
until complete paralysis is observed in all strains.  
 
Assays are completed in at least triplicate with ten to thirty worms per plate. 
Use fewer worms on assays that require shorter intervals and more plates. 
 
Two control strains are used to ensure the aldicarb plates are still good, the 
sensitive strain dgk-1(nu62) and the resistant strain unc-10(e102). Only one 
plate of each strain needs to be used and complete paralysis does not need 
to occur in unc-10(e102). 
 
1. Transfer age matched adult worms (15 is a good starting point) to aldicarb 
plates in triplicate. Do not parafilm the plates.  
 
2. Write the time on each plate to ensure plates are observed at the correct 
times. 
 
 
3. You decide how to assess paralysis. The important thing is that you’re 
consistent. See the Nature Protocols paper for suggestions. Previous assays 
in the lab have assessed paralysis by first tapping the plate to find worms that 
move freely, then by poking each worm three times in the head and three 
times in the tail to elicit a movement response. Any movement (but not a 
contraction) is counted as a worm that is not paralyzed. 
 
4. Assess paralysis in all worms at the determined time points.  
 
5. Continue assessing paralysis until all worms are paralyzed (except            
unc-10(e102)). 
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6. Calculate the percentage of worms paralyzed at each time point for each trial. 
 
7. Average the percentages across each trial at the same time point.  
 
8. Depending on the number of strains being compared, use a statistical test 
(e.g. an unpaired t-test or one-way ANOVA) to compare strains at relevant 
time points. Alternatively, the time required for half of the worms to become 
paralyzed could be calculated similar to calculating an ED50 or LD50.  
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Title: Age Synchronization by Bleaching 
 
Purpose:  
 
The purpose of this protocol is to obtain a population of worms that are the same 
age. This is accomplished by breaking apart worms with a bleaching solution that 
leaves eggs intact. The eggs are then allowed to hatch in the absence of food to 
arrest all worms at the L1 stage.  
 
Resources: 
 
Porta-de-la-Riva, M., Fontrodona, L., Villanueva, A., Cerón, J. Basic 
Caenorhabditis elegans Methods: Synchronization and Observation. J. Vis. Exp. 
(64), e4019, doi:10.3791/4019 (2012). Link: 
http://www.jove.com/video/4019/basic-caenorhabditis-elegans-methods-
synchronization-and-observation 
 
 
Method: 
 
1. Make the bleaching solution fresh by adding 2 mL of sodium hypochlorite 
(bleach) and 1 mL of 5M NaOH to 7 mL of dH2O. 
2. Wash gravid adults from plates with M9 and pipette them into a 15 mL 
conical. Eggs can also be collected by scraping the plate with a flexible piece 
of plastic.  
3. Centrifuge the conicals for 30 seconds at 1,000 x g to pellet the worms and 
eggs. This speed can be adjusted. Try to avoid pelleting the bacteria.  
4. Remove the supernatant. 
5. Add 10 mL of M9.  
6. Centrifuge the conicals for 30 seconds at 1,000 x g to pellet the worms and 
eggs.  
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7. Remove the supernatant. (Repeat the rinsing until the M9 is mostly clear. This 
will mean that most of the bacteria has been removed.) 
8. Add 1 – 2 mL (or enough to suspend the worms) of bleaching solution to the 
worm pellet.  
9. Using the dissecting scope to monitor, shake the conical until all worms have 
burst.  
10. Immediately fill the conical with M9.  
11. Centrifuge the conicals for 30 seconds at 1,000 x g to pellet the eggs. This 
speed can be adjusted. 
12. Remove the supernatant.  
13. Add 10 mL of M9.  
14. Centrifuge the conicals for 30 seconds at 1,000 x g to pellet the eggs. This 
speed can be adjusted. 
15. Remove the supernatant. 
16. Add 10 mL of M9.  
17. Centrifuge the conicals for 30 seconds at 1,000 x g to pellet the eggs. This 
speed can be adjusted. 
18. Remove the supernatant. 
19. Using a glass pipette transfer the egg pellet to a new conical with 10 mL of 
M9. 
20. Parafilm the lid clockwise to ensure the cap doesn’t come off or leak. 
21. Leave the conicals on the shaker overnight at room temperature (or at 20C if 
possible). 
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22. The next day, centrifuge the conicals for 30 seconds at 1,000 x g to pellet the 
L1s 
23. Using a glass pipette, transfer the pelleted worms to OP50 seeded NGM 
plates.  
 
 
Use: 
 This protocol can be used either to bleach contaminated plates or to synchronize 
a large number of worms for assays. Ensure that controls are also bleached and age-
matched in this manner. Ideally egg laying should be used to age match worms if 
possible. This protocol should be used when worms need to be age matched most 
closely.  
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Title: Membrane Extraction for GC/MS Analysis 
Purpose: 
The purpose of this protocol is to describe how to extract the total lipids from 
Caenorhabditis elegans for analysis by gas chromatography/mass spectrometry. 
This will allow for individual fatty acid species to be identified and quantified 
(absolute or relative). This protocol will aid in the detection of altered fatty acid 
metabolism and also confirm the intake of dietary fatty acids. 
 
Resources: 
Watts, J. L., & Browse, J. (2002). Genetic dissection of polyunsaturated fatty acid 
synthesis in Caenorhabditis elegans. Proc Natl Acad Sci U S A, 99(9), 5854-
5859. doi: 10.1073/pnas.092064799 
 
Methods: 
1. Turn on a hot plate or water bath to 80°C.  
2. Wash five plates of age synchronized, adult worms into 15 mL conicals using M9. 
3. Centrifuge the conicals for 30 seconds at 1,000 x g to pellet the worms. This 
speed can be adjusted. Try to avoid pelleting the bacteria.  
4. Remove the supernatant. 
5. Add 10 mL of M9.  
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6. Centrifuge the conicals for 30 seconds at 1,000 x g to pellet the worms again.  
7. Using a glass pipette, transfer the worm pellet to a glass vial with a screw on cap. 
Glass scintillation vials work well.   
8. Add 1 mL of 2.5% H2SO4 in methanol to each glass vial.  
9. Make sure the cap is securely fastened. It is recommended to tape the cap to the 
glass vial to ensure it stays on during the next step.  
10. Sonicate each capped vial in an ice-cold water bath sonicator for 3-5 minutes or 
until worms are completely broken apart. The sample will appear milky. 
(Sonication may also be accomplished using a probe sonicator, but this has not 
been tested). 
11. Incubate the capped vials at 80°C for 1 hour.  
12. Add 0.2 mL hexane and 1.5 mL dH2O.  
13. Shake the vials vigorously by hand and vortex.  
14. Allow the vials to sit for 5 minutes. The organic and inorganic layers should 
separate. 
15. Transfer the top, hexane layer to a new glass vial with a glass pipette. Ensure 
that you don’t get any of the debris in the interface between the layers. It is more 
important that good sample is collected than a large volume of sample.  
16. Ensure the vial is capped.  
 
Storage: 
Store sample at -80°C until they are ready for GC/MS analysis by Justin Poklis.   
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GC/MS Analysis: 
From the reference above, for GC/MS analysis: Samples (1µl) of the organic 
phase were analyzed by GC using an Agilent 6890 series gas chromatographer 
equipped with a 30 x 0.25-mm SP-2380 column (Supelco), helium as the carrier 
gas at 1.4 ml min, and a flame ionization detector. The gas chromatograph was 
programmed for an initial temperature of 120°C for 1 min followed by an increase 
of 10°C min to 190°C followed by an increase of 2°C min to 200°C. 
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Title: Lipid Raft Isolation 
Purpose: 
This protocol describes how to isolate lipid raft fractions from Caenorhabditis 
elegans membrane. This protocol can be used to assess the location/proportion 
of lipid raft interacting proteins during the exposure to ethanol. 
 
Worm Preparation for Lipid Raft Isolation 
Five L4 worms were picked to each of ten 5 cm plates, seeded with OP50. The 
subsequent F1 population was allowed to develop to gravid adults. At this stage, 
the ten plates were washed with M9 to collect worms. (See Age Synchronization 
by Bleaching) The worms were pelleted and resuspended in a bleach solution 
(20% v/v bleach with 0.5 M NaOH in dH2O) and shaken vigorously for 
approximately five minutes. M9 was added after worms had lysed but before 
eggs were damaged. The eggs were spun down and washed twice with M9. After 
the final wash, the eggs were transferred to a 15 mL conical with 10 mL of M9. 
The conical was parafilmed and allowed to shake overnight and hatch to 
synchronize the F2 population at the L1 stage. Each conical was divided, via 
pipetting, between sixty OP50-seeded 10 cm plates. The F2 population was 
allowed to develop to first day adults before testing.  
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Sixty 10 cm plates seeded in this manner will not exhaust the OP50 before the 
F2s reached adulthood. This protocol will yield approximately 1 – 2 mL of worms 
depending on strain (size, egg laying, etc).  
For seeding 10 cm plates it is suggested to use a shaken culture of OP50 or to 
allow the lawn to grow for two days prior to use.  
 
Membrane Isolation Method: 
1. Ensure that the S-Basal, homogenization buffer, and TNE with 1% Triton X-100 
are on ice (see recipes below). 
2. After EtOH exposure, wash worms from the large assay plates to 15 mL conicals 
using 5 mL of S-Basal per plate. Pool identical plates if possible. 
3. Pellet worms by immediately spinning conicals at 3,000 x g for 1 minute. 
4. Remove the supernatant. 
5. Add a volume of homogenization buffer with protease inhibitors that is sufficient 
to cover the worms. (Excess buffer will make sonication more difficult).  
6. Using a glass pipet, transfer the worms to glass scintillation vials. 
7. Sonicate the scintillation vials in a water bath sonicator with ice for approximately 
2 minutes. 
8. Ensure lysis of worms by observing the scintillation vials under the microscope 
(the solution will also become very cloudy). 
9. Transfer homogenate to 1.5 mL eppendorf tubes. 
10. Pellet cellular debris by spinning the eppendorf tubes at 1,000 x g for 5 minutes. 
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11. Transfer the supernatants from each eppendorf tube to a Beckman 
ultracentrifuge tube and spin at 60,000 x g spin for 30 minutes to pellet the 
membranes. (Balance with homogenization buffer). 
12. Resuspend the membrane pellet in the desired buffer – or – see below for lipid 
raft isolation.  
Lipid Raft Isolation Method: 
1. Pour a sucrose gradient by carefully layering 3.5 mL of 40% sucrose, 7 mL of 
35% sucrose, and 3.5 mL of 5% sucrose in a Beckman ultracentrifuge tube. 
Store the gradient at 4C for at least 15 minutes prior to use.  
2. Remove the supernatant from pelleted membrane. 
3. Resuspend each membrane pellet in 2 mL of ice-cold TNE with 1% (v/v) Triton 
X-100. (If multiple tubes were being used for a single condition, they need to be 
pooled into 2 mL of TNE). 
4. Carefully load the 2 mL of TNE with membrane on top of the sucrose gradient. 
5. Spin the sucrose gradient with membrane at 100,000 x g for 20 hours.  
6. After the spin, puncture the bottom of the tube with a hypodermic needle and 
collect one milliliter fractions in eppendorf tubes. The lipid raft fraction will appear 
as a cloudy band.  
7. Each fraction can be assessed by Bradford assay for protein content. 
8. UNC-1 can be used as a marker of lipid rafts. 
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Recipes 
M9 (1 L) 
• 6 g Na2HPO4 
• 3 g KH2PO4 
• 5 g NaCl 
• 1 mL of 1M MgSO4 
• QS to 1 L with dH2O  
• Autoclave 
• Store at RT 
 
S Basal (1 L) 
• 20 mL of 5M NaCl 
• 50 mL of 1M KPO4 (see recipe) 
• QS to 1 L with dH2O 
• Autoclave 
• 1 mL of 5 mg/mL cholesterol in 95% EtOH 
• Store at 4C 
 
KPO4 (1 L) 
• 110.26 g KH2PO4 
• 33.06 g K2HPO4 
• QS to 1 L with dH2O 
• Autoclave 
• Store at RT 
 
Bleaching Solution (10 mL) 
• 7 mL of dH2O 
• 2 mL Clorox bleach 
• 1 mL 5M NaOH 
• Make fresh 
• Volume to use will depend on the size of the worm pellet (2 mL is typically 
adequate to bleach ten 5 cm plates worth of worms).  
 
 
115 
 
Homogenization Buffer (50 mL) 
• 1 mL of 1M Tris, pH 7.4 
• 1 mL of 1M HEPES 
• 3 mL of 0.5M mannitol 
• 0.5 mL of 1M CaCl2 
• 1 mL of 0.5 mg/mL leupeptin (or equivalent protease inhibitor cocktail) 
• 1 mL of 0.5 mg/mL pepstatin (or equivalent protease inhibitor cocktail) 
• 1 mL of 0.5 mg/mL PMSF inhibitor (or equivalent protease inhibitor cocktail) 
• QS to 50 mL with dH2O 
• Make fresh 
• Keep on ice 
 
TNE with 1% Triton X-100 (10 mL) 
• 0.5 mL of 1M Tris, pH 8.0 
• 1.3 mL of 1M NaCl 
• 0.1 mL of 0.5M EDTA 
• 0.1 mL Triton X-100 
• QS to 10 mL with dH2O 
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Title: Fatty Acid Supplemented NGM Plates 
 
Purpose:  
 
This protocol describes how to pour NGM plates that are supplemented with fatty 
acid (FA) sodium salts for the purpose of dietary supplementation. These plates 
are usual for replacing missing fatty acids in fat or elo mutants or to increase the 
levels of a fatty acid in N2.  
 
 
Resources: 
 
Fatty acids can be ordered from Nu-Chek (http://www.nu-chekprep.com).  
 
The catalog can be found http://www.nu-chekprep.com/10_11_catalog.pdf and 
the “Soaps of Fatty Acids” on Page 30 are used in this protocol.  
 
Molecular weights can be found on the Certificate of Analysis included with the 
order.  
 
Watts, J. L., Phillips, E., Griffing, K. R., & Browse, J. (2003). Deficiencies in C20 
polyunsaturated fatty acids cause behavioral and developmental defects in 
Caenorhabditis elegans fat-3 mutants. Genetics, 163(2), 581-589. 
 
Deline, M. L., Vrablik, T. L., Watts, J. L. Dietary Supplementation of 
Polyunsaturated Fatty Acids in Caenorhabditis elegans. J. Vis. Exp. (81), 
e50879, doi:10.3791/50879 (2013). Link: 
http://www.jove.com/video/50879/dietary-supplementation-polyunsaturated-fatty-
acids-caenorhabditis 
 
 
 
Abbreviations: 
 
FA – Fatty Acid 
 
 
Method: 
 
1. Determine the volume of agar required based on the number of 
supplemented plates required for the assay. Repeat this step for each batch 
or fatty acid.  
 
117 
 
_________ x ____________ = __________ + 10 mL = _______ 
Number of 
plates 
 Volume per plate 
(typically 10 mL) 
 Exact volume 
required 
 Extra 
volume 
 Volume of 
agar to 
make 
 
2. Total the volume of agar being poured. You’ll need this much agar for the  
NP-40 control plates. If only one fatty acid is being used, then simply use a 
volume of agar equal to the volume determined in step 1.  
 
_________ + _________ + _________ = _________ 
First Batch  Second Batch  Third Batch  Volume of Agar 
for Control Plates 
 
3. Label an autoclavable bottle for each batch being poured with the fatty acid 
included and the concentration (e.g., Eicosapentaenoic Acid, 160 µM). Each 
bottle should hold a volume equal to approximately twice the volume of agar 
being made.  
 
4. Calculate the mass of the fatty acid that will be required. 
 
______ _________ x _____ x ________ ÷ 1,000 = ________ 
Name of 
FA 
Concentration 
(µM) 
 
 MW of 
FA 
(g/mol) 
 Volume of 
Agar (L) 
   Mass of FA 
(mg) 
 
5. Calculate the amount of water necessary to dissolve the FA to 10 mM: 
 
______ ÷ _____ ÷ _10_ x 1,000 = ________ 
Mass of FA 
(mg) 
 
 MW 
(g/mol) 
 Concentration 
(mM) 
   Volume of 
dH2O (mL) 
         
6. Dissolve the mass of FA, calculated in Step 4, in the volume of sterile dH2O, 
calculated in Step 5. Leave shaking while autoclaving the agar. If the FA is 
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not fully dissolved when the agar is ready, put the tube at 37C for 15 - 30 
minutes.  
 
7. Calculate the mass each component required for the agar: 
 
Reagent 
Amount 
per Liter 
 
Volume of 
Agar (L) 
 
Amount Required 
 
NaCl 3 g 
x 
________ 
= 
___________       g 
 
Bacto Agar 16 g 
x 
________ 
= 
___________       g 
 
Bacto Peptone 2.5 g 
x 
________ 
= 
___________       g 
 
1M K3PO4 25 mL 
x 
________ 
= 
___________    mL 
 
1M MgSO4 1 mL 
x 
________ 
= 
___________    mL 
 
1M CaCl2 1 mL 
x 
________ 
= 
___________    mL 
 
5 mg/mL Cholesterol 1 mL 
x 
________ 
= 
___________    mL 
 
NP-40 1 mL 
x 
________ 
= 
___________    mL 
 
 
8. Add the NaCl, Bacto Agar, and Bacto Peptone to the autoclavable container 
and QS to the volume required minus the volume of water needed to dissolve 
the FA in Step 5. Swirl the container.  
 
9. Either loosely screw the cap on the bottle or cover the top with tin foil and 
then add a piece of autoclave tape.  
 
10. Turn on the water bath in the plate pouring room and set it to 60C.  
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11. Autoclave for the recommended time based on the autoclave specifications.  
 
12. Place the agar in the 60C water bath for 0.5 – 1 hour.  
 
13. Add the K3PO4, MgSO4, CaCl2, cholesterol, and NP-40. This can be done in 
or out of the water bath.  
 
14. Swirl the containers to ensure the NP-40 is dissolved.  
 
15. To the “Control Plates Agar” add a volume of dH2O equal to the volume used 
to dissolve the FA in Step 5.  
 
16. Ensure the FA is dissolved in the dH2O. If not, warm the solution to 37C and 
vortex. Repeat this until the FA is in solution. Then add the 10mM FA solution 
to the “FA Agar”. 
 
17. Swirl both containers.  
 
18. Leave the FA agar in the 60C water bath while pouring the “Control Plate 
Agar”. This will allow you to use the same tubing to pour both containers. DO 
NOT USE THE SAME TUBING FOR DIFFERENT FATTY ACIDS. 
Alternatively, graduated pipettes can be used to dispense smaller batches.  
 
19. Dispense the “FA Agar” using the same settings. If the same tubing is being 
used, consider discarding the first plate poured as it may have less FA from 
residual control plate agar.  
 
20. Label the plates (color coding works well as long as you have a legend with 
the plates).  
 
21. Store plates in the dark at room temperature overnight to solidify.  
 
22. The next day, move plates to a light protected container (e.g., a box wrapped 
in tin foil) and store at either 4 or 20C.  
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Expiration: 
 
Plates have been tested out to 6 weeks stored at 20C and rescue phenotypes 
associated with loss of fatty acids. Fatty acids oxidize over time which will reduce 
the amount of usable fatty acids in the plates. This should be taken into account 
and assays should be done using the same age plates. Fatty acids should be 
stored per the recommendations of the provider. This generally means storage at 
-20C, in the dark, under an inert gas. Once opened, if stored under the proper 
conditions, the fatty acids will last 1 – 3 months. Unopened the fatty acids will last 
indefinitely.  
 
Use: 
 
Seed plates at least two days before use. Fatty acids are taken up by the E. coli 
and then are eaten by C. elegans. E. coli grows a little slower on these plates 
than on NGM plates, presumably due to the NP-40. The NP-40 will also allow 
worms to crawl between the agar and the wall of the plate. Put down extra worms 
for assays and if egglaying, recognize that not all the adults may be recoverable.  
 
For most of the previous assays, L4s were put on FA supplemented plates and 
allowed to develop to egglaying adults overnight. These adults were then moved 
to new FA supplemented plates and allowed to lay eggs for 1 – 2 hours before 
being removed. For assays that require a larger number of worms, synchronized 
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L1s (from bleached adults) can be pipetted onto FA supplemented and control 
plates. Note that development is affected by the loss of many fatty acids.  
 
For many fat mutants the basal speeds can be assessed to ensure rescue. 
Alternatively, changes in aldicarb sensitivity and egglaying can also be used. 
GC/MS should be used to measure the amount of FA present in the treated 
worms. Excess worms can be washed from plates and frozen at -80C in dH2O for 
lipid extraction at a later time.  
 
Fatty acid supplemented plates can also be used to maintain mutants that would 
otherwise be lethal (e.g., fat-5;fat-6;fat-7) or improve the mating and egglaying of 
affected strains.  
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12 Appendix II – Clarification of Contributions 
 
We are like dwarves perched on the shoulders of giants, and thus we are able to see 
more and farther than the latter. And this is not at all because of the acuteness of our 
sight or the stature of our body, but because we are carried aloft and elevated by the 
magnitude of the giants. 
Bernard of Chartres - February  15, 1676 
 
 The original idea for the LC-PUFA experiments came from a meta-analysis of 
locomotion data collected by Kapo Leung, Lindsay Kondo, and Mia Bolling under the 
direction of Dr. Jill Bettinger. Their data is not presented in this thesis, but was 
instrumental in the development of the project.  
 All GC/MS analyses, as seen in Figure 9, were completed by Justin Poklis of the 
Pharmacology and Toxicology Mass Spectrometry Core.  
 Dr. Scott Bowers provided equipment and instruction necessary for Western blot 
analysis. The data presented is my own, but would not have been possible without his 
efforts. Additionally, SLO-1 antibodies (data not shown) were kindly provided by Dr. 
Hongkyun Kim of the Rosalind Franklin University. 
 Gina Blackwell scored dgk-1(nu62) and unc-10(e102) controls for the aldicarb 
assays (data not shown).   
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 Dr. Greg Hawkins and Linsday Kondo aided in the sequencing of the fat mutants 
(data not shown). 
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13 Vita 
Richard Raabe was born on January 3, 1985 in Scarborough, Maine. He graduated 
from Scarborough High School in 2003 and went to attend the University of Richmond. 
He graduated from UR in 2007 with a Bachelor of Science in Biochemistry and 
Molecular Biology. He stayed at UR for a year as a research technician and published 
some of his work on anti-depressants interacting with a NMDA receptor subunit. He 
then went to work at Alere, Inc. as a research scientist. His work was focused on 
developing a rapid diagnostic immunoassay for influenza. He joined Dr. Jill Bettinger’s 
laboratory in the summer of 2011. 
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